0000918965 6/30 2025 Q3 false http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent 319 xbrli:shares iso4217:USD iso4217:USD xbrli:shares scsc:segment xbrli:pure 0000918965 2024-07-01 2025-03-31 0000918965 2025-05-05 0000918965 2025-03-31 0000918965 2024-06-30 0000918965 2025-01-01 2025-03-31 0000918965 2024-01-01 2024-03-31 0000918965 2023-07-01 2024-03-31 0000918965 us-gaap:CommonStockMember 2024-06-30 0000918965 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-06-30 0000918965 us-gaap:RetainedEarningsMember 2024-06-30 0000918965 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000918965 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0000918965 2024-07-01 2024-09-30 0000918965 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0000918965 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0000918965 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0000918965 us-gaap:CommonStockMember 2024-09-30 0000918965 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-09-30 0000918965 us-gaap:RetainedEarningsMember 2024-09-30 0000918965 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0000918965 2024-09-30 0000918965 us-gaap:RetainedEarningsMember 2024-10-01 2024-12-31 0000918965 2024-10-01 2024-12-31 0000918965 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-10-01 2024-12-31 0000918965 us-gaap:CommonStockMember 2024-10-01 2024-12-31 0000918965 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-10-01 2024-12-31 0000918965 us-gaap:CommonStockMember 2024-12-31 0000918965 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-12-31 0000918965 us-gaap:RetainedEarningsMember 2024-12-31 0000918965 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000918965 2024-12-31 0000918965 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0000918965 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0000918965 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0000918965 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0000918965 us-gaap:CommonStockMember 2025-03-31 0000918965 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2025-03-31 0000918965 us-gaap:RetainedEarningsMember 2025-03-31 0000918965 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0000918965 us-gaap:CommonStockMember 2023-06-30 0000918965 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-06-30 0000918965 us-gaap:RetainedEarningsMember 2023-06-30 0000918965 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000918965 2023-06-30 0000918965 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0000918965 2023-07-01 2023-09-30 0000918965 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0000918965 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0000918965 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0000918965 us-gaap:CommonStockMember 2023-09-30 0000918965 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-09-30 0000918965 us-gaap:RetainedEarningsMember 2023-09-30 0000918965 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0000918965 2023-09-30 0000918965 us-gaap:RetainedEarningsMember 2023-10-01 2023-12-31 0000918965 2023-10-01 2023-12-31 0000918965 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-10-01 2023-12-31 0000918965 us-gaap:CommonStockMember 2023-10-01 2023-12-31 0000918965 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-10-01 2023-12-31 0000918965 us-gaap:CommonStockMember 2023-12-31 0000918965 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-12-31 0000918965 us-gaap:RetainedEarningsMember 2023-12-31 0000918965 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000918965 2023-12-31 0000918965 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000918965 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000918965 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000918965 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000918965 us-gaap:CommonStockMember 2024-03-31 0000918965 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-03-31 0000918965 us-gaap:RetainedEarningsMember 2024-03-31 0000918965 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000918965 2024-03-31 0000918965 2024-07-01 2024-07-01 0000918965 us-gaap:BankOverdraftsMember 2025-03-31 0000918965 us-gaap:BankOverdraftsMember 2024-06-30 0000918965 us-gaap:ProductMember 2025-01-01 2025-03-31 0000918965 us-gaap:ProductMember 2024-07-01 2025-03-31 0000918965 us-gaap:ProductMember 2024-01-01 2024-03-31 0000918965 us-gaap:ProductMember 2023-07-01 2024-03-31 0000918965 scsc:ProductsAndServicesMember scsc:SpecialtyTechnologySolutionsMember 2025-01-01 2025-03-31 0000918965 scsc:ProductsAndServicesMember scsc:IntelisysAdvisoryMember 2025-01-01 2025-03-31 0000918965 scsc:ProductsAndServicesMember 2025-01-01 2025-03-31 0000918965 scsc:RecurringRevenueMember scsc:SpecialtyTechnologySolutionsMember 2025-01-01 2025-03-31 0000918965 scsc:RecurringRevenueMember scsc:IntelisysAdvisoryMember 2025-01-01 2025-03-31 0000918965 scsc:RecurringRevenueMember 2025-01-01 2025-03-31 0000918965 scsc:SpecialtyTechnologySolutionsMember 2025-01-01 2025-03-31 0000918965 scsc:IntelisysAdvisoryMember 2025-01-01 2025-03-31 0000918965 scsc:ProductsAndServicesMember scsc:SpecialtyTechnologySolutionsMember 2024-07-01 2025-03-31 0000918965 scsc:ProductsAndServicesMember scsc:IntelisysAdvisoryMember 2024-07-01 2025-03-31 0000918965 scsc:ProductsAndServicesMember 2024-07-01 2025-03-31 0000918965 scsc:RecurringRevenueMember scsc:SpecialtyTechnologySolutionsMember 2024-07-01 2025-03-31 0000918965 scsc:RecurringRevenueMember scsc:IntelisysAdvisoryMember 2024-07-01 2025-03-31 0000918965 scsc:RecurringRevenueMember 2024-07-01 2025-03-31 0000918965 scsc:SpecialtyTechnologySolutionsMember 2024-07-01 2025-03-31 0000918965 scsc:IntelisysAdvisoryMember 2024-07-01 2025-03-31 0000918965 scsc:ProductsAndServicesMember scsc:SpecialtyTechnologySolutionsMember 2024-01-01 2024-03-31 0000918965 scsc:ProductsAndServicesMember scsc:IntelisysAdvisoryMember 2024-01-01 2024-03-31 0000918965 scsc:ProductsAndServicesMember 2024-01-01 2024-03-31 0000918965 scsc:RecurringRevenueMember scsc:SpecialtyTechnologySolutionsMember 2024-01-01 2024-03-31 0000918965 scsc:RecurringRevenueMember scsc:IntelisysAdvisoryMember 2024-01-01 2024-03-31 0000918965 scsc:RecurringRevenueMember 2024-01-01 2024-03-31 0000918965 scsc:SpecialtyTechnologySolutionsMember 2024-01-01 2024-03-31 0000918965 scsc:IntelisysAdvisoryMember 2024-01-01 2024-03-31 0000918965 scsc:ProductsAndServicesMember scsc:SpecialtyTechnologySolutionsMember 2023-07-01 2024-03-31 0000918965 scsc:ProductsAndServicesMember scsc:IntelisysAdvisoryMember 2023-07-01 2024-03-31 0000918965 scsc:ProductsAndServicesMember 2023-07-01 2024-03-31 0000918965 scsc:RecurringRevenueMember scsc:SpecialtyTechnologySolutionsMember 2023-07-01 2024-03-31 0000918965 scsc:RecurringRevenueMember scsc:IntelisysAdvisoryMember 2023-07-01 2024-03-31 0000918965 scsc:RecurringRevenueMember 2023-07-01 2024-03-31 0000918965 scsc:SpecialtyTechnologySolutionsMember 2023-07-01 2024-03-31 0000918965 scsc:IntelisysAdvisoryMember 2023-07-01 2024-03-31 0000918965 us-gaap:AccumulatedTranslationAdjustmentMember 2025-03-31 0000918965 us-gaap:AccumulatedTranslationAdjustmentMember 2024-06-30 0000918965 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-03-31 0000918965 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-06-30 0000918965 scsc:SpecialtyTechnologySolutionsMember 2024-06-30 0000918965 scsc:IntelisysAdvisoryMember 2024-06-30 0000918965 scsc:SpecialtyTechnologySolutionsMember 2025-03-31 0000918965 scsc:IntelisysAdvisoryMember 2025-03-31 0000918965 scsc:MississippiRevenueBondMember 2025-03-31 0000918965 scsc:MississippiRevenueBondMember 2024-06-30 0000918965 scsc:TermLoanFacilityMember 2025-03-31 0000918965 scsc:TermLoanFacilityMember 2024-06-30 0000918965 scsc:MultiCurrencyRevolvingCreditFacilityMember 2025-03-31 0000918965 scsc:MultiCurrencyRevolvingCreditFacilityMember 2024-06-30 0000918965 scsc:MultiCurrencyRevolvingCreditFacilityAmendedCreditAgreementMember 2022-09-28 2022-09-28 0000918965 scsc:MultiCurrencyRevolvingCreditFacilityAmendedCreditAgreementMember 2022-09-28 0000918965 scsc:TermLoanFacilityMember 2022-09-28 2022-09-28 0000918965 scsc:TermLoanFacilityMember 2022-09-28 0000918965 us-gaap:LetterOfCreditMember 2022-09-28 0000918965 scsc:MultiCurrencyRevolvingCreditFacilityAmendedCreditAgreementMember us-gaap:SecuredOvernightFinancingRateSofrMember srt:MinimumMember 2024-07-01 2025-03-31 0000918965 scsc:MultiCurrencyRevolvingCreditFacilityAmendedCreditAgreementMember us-gaap:SecuredOvernightFinancingRateSofrMember srt:MaximumMember 2024-07-01 2025-03-31 0000918965 scsc:MultiCurrencyRevolvingCreditFacilityAmendedCreditAgreementMember 2025-03-31 0000918965 scsc:MultiCurrencyRevolvingCreditFacilityAmendedCreditAgreementMember scsc:AlternateBaseRateLoansMember srt:MinimumMember 2024-07-01 2025-03-31 0000918965 scsc:MultiCurrencyRevolvingCreditFacilityAmendedCreditAgreementMember scsc:AlternateBaseRateLoansMember srt:MaximumMember 2024-07-01 2025-03-31 0000918965 scsc:MultiCurrencyRevolvingCreditFacilityAmendedCreditAgreementMember us-gaap:SecuredOvernightFinancingRateSofrMember 2024-07-01 2025-03-31 0000918965 srt:MinimumMember scsc:MultiCurrencyRevolvingCreditFacilityAmendedCreditAgreementMember 2024-07-01 2025-03-31 0000918965 srt:MaximumMember scsc:MultiCurrencyRevolvingCreditFacilityAmendedCreditAgreementMember 2024-07-01 2025-03-31 0000918965 scsc:MultiCurrencyRevolvingCreditFacilityAmendedCreditAgreementMember scsc:AlternateBaseRateLoansMember 2024-07-01 2025-03-31 0000918965 scsc:MultiCurrencyRevolvingCreditFacilityAmendedCreditAgreementMember 2024-07-01 2025-03-31 0000918965 srt:MaximumMember scsc:MultiCurrencyRevolvingCreditFacilityAmendedCreditAgreementMember 2025-03-31 0000918965 srt:MinimumMember scsc:MultiCurrencyRevolvingCreditFacilityAmendedCreditAgreementMember 2025-03-31 0000918965 scsc:MultiCurrencyRevolvingCreditFacilityAmendedCreditAgreementMember 2023-07-01 2024-03-31 0000918965 scsc:MultiCurrencyRevolvingCreditFacilityAmendedCreditAgreementMember 2024-06-30 0000918965 scsc:MississippiRevenueBondMember us-gaap:SecuredOvernightFinancingRateSofrMember 2007-08-01 2007-08-01 0000918965 scsc:MississippiRevenueBondMember 2007-08-01 2007-08-01 0000918965 us-gaap:ForeignExchangeContractMember 2025-03-31 0000918965 us-gaap:ForeignExchangeContractMember 2024-06-30 0000918965 us-gaap:InterestRateSwapMember 2022-09-28 0000918965 scsc:InterestRateSwapMaturingApril302024Member 2022-09-28 0000918965 scsc:InterestRateSwapMaturingApril302026Member 2022-09-28 0000918965 scsc:InterestRateSwapMaturingMarch312028Member 2023-03-31 0000918965 us-gaap:InterestRateSwapMember 2025-01-01 2025-03-31 0000918965 us-gaap:InterestRateSwapMember 2024-01-01 2024-03-31 0000918965 us-gaap:InterestRateSwapMember 2024-07-01 2025-03-31 0000918965 us-gaap:InterestRateSwapMember 2023-07-01 2024-03-31 0000918965 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2025-03-31 0000918965 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2025-03-31 0000918965 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2024-06-30 0000918965 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2024-06-30 0000918965 scsc:ForeignCurrencyHedgeMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2025-03-31 0000918965 scsc:ForeignCurrencyHedgeMember us-gaap:NondesignatedMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2025-03-31 0000918965 scsc:ForeignCurrencyHedgeMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2024-06-30 0000918965 scsc:ForeignCurrencyHedgeMember us-gaap:NondesignatedMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2024-06-30 0000918965 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentAssetsMember 2025-03-31 0000918965 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember us-gaap:OtherNoncurrentAssetsMember 2025-03-31 0000918965 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentAssetsMember 2024-06-30 0000918965 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember us-gaap:OtherNoncurrentAssetsMember 2024-06-30 0000918965 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember scsc:AccruedLiabilitiesAndOtherCurrentLiabilitiesMember 2025-03-31 0000918965 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember scsc:AccruedLiabilitiesAndOtherCurrentLiabilitiesMember 2025-03-31 0000918965 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember scsc:AccruedLiabilitiesAndOtherCurrentLiabilitiesMember 2024-06-30 0000918965 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember scsc:AccruedLiabilitiesAndOtherCurrentLiabilitiesMember 2024-06-30 0000918965 us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000918965 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000918965 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000918965 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000918965 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2025-03-31 0000918965 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000918965 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000918965 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000918965 us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateSwapMember 2025-03-31 0000918965 us-gaap:FairValueInputsLevel1Member us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000918965 us-gaap:FairValueInputsLevel2Member us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000918965 us-gaap:FairValueInputsLevel3Member us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000918965 us-gaap:FairValueMeasurementsRecurringMember scsc:ForeignCurrencyHedgeMember 2025-03-31 0000918965 us-gaap:FairValueInputsLevel1Member scsc:ForeignCurrencyHedgeMember us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000918965 us-gaap:FairValueInputsLevel2Member scsc:ForeignCurrencyHedgeMember us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000918965 us-gaap:FairValueInputsLevel3Member scsc:ForeignCurrencyHedgeMember us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000918965 us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0000918965 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0000918965 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0000918965 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0000918965 us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateSwapMember 2024-06-30 0000918965 us-gaap:FairValueInputsLevel1Member us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0000918965 us-gaap:FairValueInputsLevel2Member us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0000918965 us-gaap:FairValueInputsLevel3Member us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0000918965 us-gaap:FairValueMeasurementsRecurringMember scsc:ForeignCurrencyHedgeMember 2024-06-30 0000918965 us-gaap:FairValueInputsLevel1Member scsc:ForeignCurrencyHedgeMember us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0000918965 us-gaap:FairValueInputsLevel2Member scsc:ForeignCurrencyHedgeMember us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0000918965 us-gaap:FairValueInputsLevel3Member scsc:ForeignCurrencyHedgeMember us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0000918965 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2024-06-30 0000918965 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0000918965 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0000918965 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0000918965 us-gaap:FairValueInputsLevel3Member scsc:SegmentAMember 2024-12-31 0000918965 us-gaap:FairValueInputsLevel3Member scsc:SegmentBMember 2024-12-31 0000918965 us-gaap:FairValueInputsLevel3Member 2024-12-31 0000918965 us-gaap:FairValueInputsLevel3Member scsc:SegmentAMember 2025-01-01 2025-03-31 0000918965 us-gaap:FairValueInputsLevel3Member scsc:SegmentBMember 2025-01-01 2025-03-31 0000918965 us-gaap:FairValueInputsLevel3Member 2025-01-01 2025-03-31 0000918965 us-gaap:FairValueInputsLevel3Member scsc:SegmentAMember 2025-03-31 0000918965 us-gaap:FairValueInputsLevel3Member scsc:SegmentBMember 2025-03-31 0000918965 us-gaap:FairValueInputsLevel3Member 2025-03-31 0000918965 us-gaap:FairValueInputsLevel3Member scsc:SegmentAMember 2024-06-30 0000918965 us-gaap:FairValueInputsLevel3Member scsc:SegmentBMember 2024-06-30 0000918965 us-gaap:FairValueInputsLevel3Member 2024-06-30 0000918965 us-gaap:FairValueInputsLevel3Member scsc:SegmentAMember 2024-07-01 2025-03-31 0000918965 us-gaap:FairValueInputsLevel3Member scsc:SegmentBMember 2024-07-01 2025-03-31 0000918965 us-gaap:FairValueInputsLevel3Member 2024-07-01 2025-03-31 0000918965 scsc:AdvantixMember us-gaap:FairValueInputsLevel3Member 2025-03-31 0000918965 scsc:ResourciveMember us-gaap:FairValueInputsLevel3Member 2025-03-31 0000918965 scsc:MeasurementInputEBITDARiskPremiumMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2025-03-31 0000918965 us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2025-03-31 0000918965 scsc:MeasurementInputEBITDARiskPremiumMember scsc:ValuationTechniqueMonteCarloMember 2025-03-31 0000918965 scsc:SimulatedCommissionGrowthPercentageMember scsc:ValuationTechniqueMonteCarloMember 2025-03-31 0000918965 us-gaap:OperatingSegmentsMember scsc:SpecialtyTechnologySolutionsMember 2025-01-01 2025-03-31 0000918965 us-gaap:OperatingSegmentsMember scsc:SpecialtyTechnologySolutionsMember 2024-01-01 2024-03-31 0000918965 us-gaap:OperatingSegmentsMember scsc:SpecialtyTechnologySolutionsMember 2024-07-01 2025-03-31 0000918965 us-gaap:OperatingSegmentsMember scsc:SpecialtyTechnologySolutionsMember 2023-07-01 2024-03-31 0000918965 us-gaap:OperatingSegmentsMember scsc:IntelisysAdvisoryMember 2025-01-01 2025-03-31 0000918965 us-gaap:OperatingSegmentsMember scsc:IntelisysAdvisoryMember 2024-01-01 2024-03-31 0000918965 us-gaap:OperatingSegmentsMember scsc:IntelisysAdvisoryMember 2024-07-01 2025-03-31 0000918965 us-gaap:OperatingSegmentsMember scsc:IntelisysAdvisoryMember 2023-07-01 2024-03-31 0000918965 us-gaap:CorporateNonSegmentMember 2025-01-01 2025-03-31 0000918965 us-gaap:CorporateNonSegmentMember 2024-01-01 2024-03-31 0000918965 us-gaap:CorporateNonSegmentMember 2024-07-01 2025-03-31 0000918965 us-gaap:CorporateNonSegmentMember 2023-07-01 2024-03-31 0000918965 scsc:UnitedStatesandCanadaMember srt:ReportableGeographicalComponentsMember 2025-01-01 2025-03-31 0000918965 scsc:UnitedStatesandCanadaMember srt:ReportableGeographicalComponentsMember 2024-01-01 2024-03-31 0000918965 scsc:UnitedStatesandCanadaMember srt:ReportableGeographicalComponentsMember 2024-07-01 2025-03-31 0000918965 scsc:UnitedStatesandCanadaMember srt:ReportableGeographicalComponentsMember 2023-07-01 2024-03-31 0000918965 country:BR srt:ReportableGeographicalComponentsMember 2025-01-01 2025-03-31 0000918965 country:BR srt:ReportableGeographicalComponentsMember 2024-01-01 2024-03-31 0000918965 country:BR srt:ReportableGeographicalComponentsMember 2024-07-01 2025-03-31 0000918965 country:BR srt:ReportableGeographicalComponentsMember 2023-07-01 2024-03-31 0000918965 srt:GeographyEliminationsMember 2025-01-01 2025-03-31 0000918965 srt:GeographyEliminationsMember 2024-01-01 2024-03-31 0000918965 srt:GeographyEliminationsMember 2024-07-01 2025-03-31 0000918965 srt:GeographyEliminationsMember 2023-07-01 2024-03-31 0000918965 us-gaap:NonUsMember 2025-01-01 2025-03-31 0000918965 us-gaap:NonUsMember us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2025-01-01 2025-03-31 0000918965 us-gaap:NonUsMember 2024-07-01 2025-03-31 0000918965 us-gaap:NonUsMember us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2024-07-01 2025-03-31 0000918965 us-gaap:NonUsMember 2024-01-01 2024-03-31 0000918965 us-gaap:NonUsMember us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2024-01-01 2024-03-31 0000918965 us-gaap:NonUsMember 2023-07-01 2024-03-31 0000918965 us-gaap:NonUsMember us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2023-07-01 2024-03-31 0000918965 us-gaap:OperatingSegmentsMember scsc:SpecialtyTechnologySolutionsMember us-gaap:SegmentContinuingOperationsMember 2025-03-31 0000918965 us-gaap:OperatingSegmentsMember scsc:SpecialtyTechnologySolutionsMember us-gaap:SegmentContinuingOperationsMember 2024-06-30 0000918965 us-gaap:OperatingSegmentsMember scsc:IntelisysAdvisoryMember us-gaap:SegmentContinuingOperationsMember 2025-03-31 0000918965 us-gaap:OperatingSegmentsMember scsc:IntelisysAdvisoryMember us-gaap:SegmentContinuingOperationsMember 2024-06-30 0000918965 scsc:UnitedStatesandCanadaMember 2025-03-31 0000918965 scsc:UnitedStatesandCanadaMember 2024-06-30 0000918965 country:BR 2025-03-31 0000918965 country:BR 2024-06-30 0000918965 srt:MinimumMember 2025-03-31 0000918965 srt:MaximumMember 2025-03-31 0000918965 scsc:Network1Member 2025-03-31 0000918965 scsc:Network1Member 2024-06-30 0000918965 2024-01-01 2024-01-31 0000918965 2024-09-01 2024-09-30 0000918965 us-gaap:EmployeeSeveranceMember 2025-01-01 2025-03-31 0000918965 us-gaap:EmployeeSeveranceMember 2024-07-01 2025-03-31 0000918965 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2024-07-01 2025-03-31 0000918965 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-01-01 2025-03-31 0000918965 us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember scsc:UKBasedIntYBusinessMember 2023-12-19 2023-12-19 0000918965 us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember 2024-10-01 2024-12-31 0000918965 scsc:RachelHaydenMember 2025-01-01 2025-03-31 0000918965 scsc:RachelHaydenMember 2025-03-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2025
OR

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____ to ____
Commission File Number: 000-26926

|  | ScanSource, Inc. |  |
| (Exact name of registrant as specified in its charter) |
South Carolina |  | 57-0965380
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)
6 Logue Court |  | 29615
Greenville, South Carolina |  | (Zip Code)
(Address of principal executive offices) |  |  |

(864) 288-2432
(Registrant's telephone number, including area code)
_______________________________________________
Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class |  | Trading Symbol |  | Name of Each Exchange on Which Registered
Common Stock, no par value |  | SCSC |  | NASDAQ Global Select Market

Securities registered pursuant to Section 12(g) of the Act:
None.
_______________________________________________
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer | ☒ |  | Smaller reporting company | ☐ |
Accelerated filer | ☐ |  | Emerging growth company | ☐ |
Non-accelerated filer | ☐ |  |  |  |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class |  | Outstanding at May 5, 2025
Common Stock, no par value per share |  | 22,595,608 shares

SCANSOURCE, INC.
INDEX TO FORM 10-Q
March 31, 2025

|  | Page #
PART I. FINANCIAL INFORMATION |
Item 1. | Financial Statements | 5
| Condensed Consolidated Balance Sheets (unaudited) at March 31, 2025 and June 30, 2024 | 5
| Condensed Consolidated Income Statements (unaudited) for the Quarters and Nine Months ended March 31, 2025 and 2024 | 6
| Condensed Consolidated Statements of Comprehensive Income (unaudited) for the Quarters and Nine Months ended March 31, 2025 and 2024 | 7
| Condensed Consolidated Statements of Shareholders' Equity (unaudited) for the Quarters and Nine Months ended March 31, 2025 and 2024 | 8
| Condensed Consolidated Statements of Cash Flows (unaudited) for the Nine Months Ended March 31, 2025 and 2024 | 10
| Notes to Condensed Consolidated Financial Statements (unaudited) | 11
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 27
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 47
Item 4. | Controls and Procedures | 48
PART II. OTHER INFORMATION |
Item 1. | Legal Proceedings | 49
Item 1A. | Risk Factors | 49
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 49
Item 5. | Other Information | 50
Item 6. | Exhibits | 51
SIGNATURES | 52

3

Table of Contents
FORWARD-LOOKING STATEMENTS
Forward-looking statements are included in the "Risk Factors," "Legal Proceedings," "Management’s Discussion and Analysis of Financial Condition and Results of Operations," and "Quantitative and Qualitative Disclosures About Market Risk" sections and elsewhere herein. Words such as "expects," "anticipates," "believes," "intends," "plans," "hopes," "forecasts," "seeks," "estimates," "goals," "projects," "strategy," "future," "likely," "may," "should," "will," and variations of such words and similar expressions generally identify such forward-looking statements. Any forward-looking statement made by us in this Form 10-Q is based only on information currently available to us and speaks only as of the date on which it is made. Except as may be required by law, we expressly disclaim any obligation to update these forward-looking statements to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q. These forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond our control. You should not place undue reliance on forward-looking statements as actual results could differ materially from those anticipated in these forward-looking statements as a result of a number of factors including, but not limited to the following factors, which are neither presented in order of importance nor weighted: macroeconomic conditions, including potential prolonged economic weakness, inflation and supply chain challenges, tariffs and changes in trade policy, the failure to manage and implement the Company's growth strategy, the Company's ability to realize the synergies or other benefits from acquisitions, credit risks involving the Company's larger customers and suppliers, changes in interest and exchange rates and regulatory regimes impacting the Company's international operations, risk to the Company's business from a cyber attack, a failure of the Company's IT systems, failure to hire and retain quality employees, loss of the Company's major customers, relationships with the Company's key suppliers and channel partners or a termination or a significant modification of the terms under which it operates with such suppliers and channel partners, changes in the Company's operating strategy and other factors set forth in "Risk Factors" contained in our Annual Report on Form 10-K for the year ended June 30, 2024.
4

Table of Contents
PART I. FINANCIAL INFORMATION

Item 1. | Financial Statements

SCANSOURCE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(In thousands, except share information)

| March 31, 2025 |  | June 30, 2024
Assets |  |  |
Current assets: |  |  |
Cash and cash equivalents | $ | 146,287 |  |  | $ | 185,460 |
Accounts receivable, less allowance of $27,032 at March 31, 2025 and $20,684 at June 30, 2024 | 562,820 |  |  | 581,523 |
Inventories | 476,206 |  |  | 512,634 |
Prepaid expenses and other current assets | 124,955 |  |  | 125,082 |
Total current assets | 1,310,268 |  |  | 1,404,699 |
Property and equipment, net | 29,997 |  |  | 33,501 |
Goodwill | 228,835 |  |  | 206,301 |
Identifiable intangible assets, net | 67,815 |  |  | 37,634 |
Deferred income taxes | 17,947 |  |  | 19,902 |
Other non-current assets | 70,346 |  |  | 76,995 |
Total assets | $ | 1,725,208 |  |  | $ | 1,779,032 |
Liabilities and Shareholders’ Equity |  |  |
Current liabilities: |  |  |
Accounts payable | $ | 540,765 |  |  | $ | 587,984 |
Accrued expenses and other current liabilities | 68,263 |  |  | 65,616 |
Current portion of contingent consideration | 1,737 |  |  | — |
Income taxes payable | 13,224 |  |  | 7,895 |
Current portion of long-term debt | 7,861 |  |  | 7,857 |
Total current liabilities | 631,850 |  |  | 669,352 |
Long-term debt, net of current portion | 130,163 |  |  | 136,149 |
Borrowings under revolving credit facility | — |  |  | 50 |
Long-term portion of contingent consideration | 17,510 |  |  | — |
Other long-term liabilities | 43,939 |  |  | 49,226 |
Total liabilities | 823,462 |  |  | 854,777 |
Commitments and contingencies |  |  |
Shareholders’ equity: |  |  |
Preferred stock, no par value; 3,000,000 shares authorized, none issued | — |  |  | — |
Common stock, no par value; 45,000,000 shares authorized, 22,894,413 and 24,243,848 shares issued and outstanding at March 31, 2025 and June 30, 2024, respectively | — |  |  | 26,370 |
Retained earnings | 1,023,399 |  |  | 1,013,738 |
Accumulated other comprehensive loss | (121,653) |  |  | (115,853) |
Total shareholders’ equity | 901,746 |  |  | 924,255 |
Total liabilities and shareholders’ equity | $ | 1,725,208 |  |  | $ | 1,779,032 |
June 30, 2024 amounts are derived from audited consolidated financial statements.
See accompanying notes to these condensed consolidated financial statements.

5

Table of Contents
SCANSOURCE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED INCOME STATEMENTS (UNAUDITED)
(In thousands, except per share data)

| Quarter ended |  | Nine months ended
| March 31, |  | March 31,
| 2025 |  | 2024 |  | 2025 |  | 2024
Net sales | $ | 704,847 |  |  | $ | 752,599 |  |  | $ | 2,227,924 |  |  | $ | 2,513,696 |
Cost of goods sold | 604,645 |  |  | 658,118 |  |  | 1,924,380 |  |  | 2,211,958 |
Gross profit | 100,202 |  |  | 94,481 |  |  | 303,544 |  |  | 301,738 |
Selling, general and administrative expenses | 69,698 |  |  | 66,574 |  |  | 215,324 |  |  | 208,930 |
Depreciation expense | 2,320 |  |  | 2,690 |  |  | 8,079 |  |  | 8,449 |
Intangible amortization expense | 4,941 |  |  | 3,752 |  |  | 14,300 |  |  | 11,982 |
Restructuring expense | — |  |  | 3,923 |  |  | 5,381 |  |  | 3,923 |
Change in fair value of contingent consideration | 904 |  |  | — |  |  | 2,047 |  |  | — |
Operating income | 22,339 |  |  | 17,542 |  |  | 58,413 |  |  | 68,454 |
Interest expense | 1,836 |  |  | 2,001 |  |  | 5,914 |  |  | 10,947 |
Interest income | (2,841) |  |  | (2,652) |  |  | (8,193) |  |  | (6,096) |
Gain on sale of business | — |  |  | — |  |  | — |  |  | (14,533) |
Other (income) expense, net | (882) |  |  | 241 |  |  | (6,206) |  |  | 991 |
Income before income taxes | 24,226 |  |  | 17,952 |  |  | 66,898 |  |  | 77,145 |
Provision for income taxes | 6,795 |  |  | 5,146 |  |  | 15,440 |  |  | 16,181 |
Net income | $ | 17,431 |  |  | $ | 12,806 |  |  | $ | 51,458 |  |  | $ | 60,964 |
Per share data: |  |  |  |  |  |  |
Net income per common share, basic | $ | 0.75 |  |  | $ | 0.51 |  |  | $ | 2.17 |  |  | $ | 2.44 |
Weighted-average shares outstanding, basic | 23,275 |  |  | 25,025 |  |  | 23,746 |  |  | 24,982 |
Net income per common share, diluted | $ | 0.74 |  |  | $ | 0.50 |  |  | $ | 2.13 |  |  | $ | 2.41 |
Weighted-average shares outstanding, diluted | 23,604 |  |  | 25,437 |  |  | 24,165 |  |  | 25,291 |

See accompanying notes to these condensed consolidated financial statements.

6

Table of Contents
SCANSOURCE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
(In thousands)

| Quarter ended |  | Nine months ended
| March 31, |  | March 31,
| 2025 |  | 2024 |  | 2025 |  | 2024
Net income | $ | 17,431 |  |  | $ | 12,806 |  |  | $ | 51,458 |  |  | $ | 60,964 |
Unrealized (loss) gain on hedged transaction, net of tax | (462) |  |  | 148 |  |  | (1,245) |  |  | (1,246) |
Realized foreign currency on sale of business | — |  |  | — |  |  | — |  |  | (3,805) |
Foreign currency translation adjustment | 10,081 |  |  | (4,947) |  |  | (4,555) |  |  | (5,345) |
Comprehensive income | $ | 27,050 |  |  | $ | 8,007 |  |  | $ | 45,658 |  |  | $ | 50,568 |

See accompanying notes to these condensed consolidated financial statements.

7

Table of Contents
SCANSOURCE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED)
(In thousands, except share information)

| Common Stock (Shares) |  | Common Stock (Amount) |  | Retained Earnings |  | Accumulated Other Comprehensive Loss |  | Total
Balance at June 30, 2024 | 24,243,848 |  |  | $ | 26,370 |  |  | $ | 1,013,738 |  |  | $ | (115,853) |  |  | $ | 924,255 |
Net income | — |  |  | — |  |  | 16,974 |  |  | — |  |  | 16,974 |
Unrealized loss on hedged transaction, net of tax | — |  |  | — |  |  | — |  |  | (1,050) |  |  | (1,050) |
Foreign currency translation adjustment | — |  |  | — |  |  | — |  |  | 4,109 |  |  | 4,109 |
Exercise of stock options and shares issued under share-based compensation plans, net of shares withheld for employee taxes | 349,277 |  |  | 2,177 |  |  | — |  |  | — |  |  | 2,177 |
Common stock repurchased, including excise tax | (588,018) |  |  | (28,043) |  |  | — |  |  | — |  |  | (28,043) |
Share-based compensation | — |  |  | 2,471 |  |  | — |  |  | — |  |  | 2,471 |
Balance at September 30, 2024 | 24,005,107 |  |  | $ | 2,975 |  |  | $ | 1,030,712 |  |  | $ | (112,794) |  |  | $ | 920,893 |
Net income | — |  |  | $ | — |  |  | $ | 17,053 |  |  | $ | — |  |  | $ | 17,053 |
Unrealized gain on hedged transaction, net of tax | — |  |  | — |  |  | — |  |  | 266 |  |  | 266 |
Foreign currency translation adjustment | — |  |  | — |  |  | — |  |  | (18,744) |  |  | (18,744) |
Exercise of stock options and shares issued under share-based compensation plans, net of shares withheld for employee taxes | 102,489 |  |  | 2,508 |  |  | — |  |  | — |  |  | 2,508 |
Common stock repurchased, including excise tax | (495,053) |  |  | (8,504) |  |  | (15,831) |  |  | — |  |  | (24,335) |
Share-based compensation | — |  |  | 3,021 |  |  | — |  |  | — |  |  | 3,021 |
Balance at December 31, 2024 | 23,612,543 |  |  | $ | — |  |  | $ | 1,031,934 |  |  | $ | (131,272) |  |  | $ | 900,662 |
Net income | — |  |  | $ | — |  |  | $ | 17,431 |  |  | $ | — |  |  | $ | 17,431 |
Unrealized loss on hedged transaction, net of tax | — |  |  | — |  |  | — |  |  | (462) |  |  | (462) |
Foreign currency translation adjustment | — |  |  | — |  |  | — |  |  | 10,081 |  |  | 10,081 |
Exercise of stock options and shares issued under share-based compensation plans, net of shares withheld for employee taxes | 1,063 |  |  | — |  |  | — |  |  | — |  |  | — |
Common stock repurchased, including excise tax | (719,193) |  |  | (2,899) |  |  | (25,966) |  |  | — |  |  | (28,865) |
Share-based compensation | — |  |  | 2,899 |  |  | — |  |  | — |  |  | 2,899 |
Balance at March 31, 2025 | 22,894,413 |  |  | $ | — |  |  | $ | 1,023,399 |  |  | $ | (121,653) |  |  | $ | 901,746 |
See accompanying notes to these condensed consolidated financial statements.

8

Table of Contents
SCANSOURCE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED)
(In thousands, except share information)

| Common Stock (Shares) |  | Common Stock (Amount) |  | Retained Earnings |  | Accumulated Other Comprehensive Loss |  | Total
Balance at June 30, 2023 | 24,844,203 |  |  | $ | 58,241 |  |  | $ | 936,678 |  |  | $ | (89,621) |  |  | $ | 905,298 |
Net income | — |  |  | — |  |  | 15,432 |  |  | — |  |  | 15,432 |
Unrealized gain on hedged transaction, net of tax | — |  |  | — |  |  | — |  |  | 153 |  |  | 153 |
Foreign currency translation adjustment | — |  |  | — |  |  | — |  |  | (6,890) |  |  | (6,890) |
Exercise of stock options and shares issued under share-based compensation plans, net of shares withheld for employee taxes | 116,028 |  |  | (1,510) |  |  | — |  |  | — |  |  | (1,510) |
Share-based compensation | — |  |  | 2,770 |  |  | — |  |  | — |  |  | 2,770 |
Balance at September 30, 2023 | 24,960,231 |  |  | $ | 59,501 |  |  | $ | 952,110 |  |  | $ | (96,358) |  |  | $ | 915,253 |
Net income | — |  |  | $ | — |  |  | $ | 32,726 |  |  | $ | — |  |  | $ | 32,726 |
Unrealized loss on hedged transaction, net of tax | — |  |  | — |  |  | — |  |  | (1,547) |  |  | (1,547) |
Foreign currency translation adjustment | — |  |  | — |  |  | — |  |  | 6,492 |  |  | 6,492 |
Realized foreign currency on sale of business | — |  |  | — |  |  | — |  |  | (3,805) |  |  | (3,805) |
Exercise of stock options and shares issued under share-based compensation plans, net of shares withheld for employee taxes | 230,543 |  |  | 3,162 |  |  | — |  |  | — |  |  | 3,162 |
Common stock repurchased, including excise tax | (36,305) |  |  | (1,251) |  |  | — |  |  | — |  |  | (1,251) |
Share-based compensation | — |  |  | 2,571 |  |  | — |  |  | — |  |  | 2,571 |
Balance at December 31, 2023 | 25,154,469 |  |  | $ | 63,983 |  |  | $ | 984,836 |  |  | $ | (95,218) |  |  | $ | 953,601 |
Net income | — |  |  | $ | — |  |  | $ | 12,806 |  |  | $ | — |  |  | $ | 12,806 |
Unrealized gain on hedged transaction, net of tax | — |  |  | — |  |  | — |  |  | 148 |  |  | 148 |
Foreign currency translation adjustment | — |  |  | — |  |  | — |  |  | (4,947) |  |  | (4,947) |
Exercise of stock options and shares issued under share-based compensation plans, net of shares withheld for employee taxes | 24,220 |  |  | 180 |  |  | — |  |  | — |  |  | 180 |
Common stock repurchased, including excise tax | (469,881) |  |  | (20,117) |  |  | — |  |  | — |  |  | (20,117) |
Share-based compensation | — |  |  | 2,380 |  |  | — |  |  | — |  |  | 2,380 |
Balance at March 31, 2024 | 24,708,808 |  |  | $ | 46,426 |  |  | $ | 997,642 |  |  | $ | (100,017) |  |  | $ | 944,051 |
See accompanying notes to these condensed consolidated financial statements.

9

Table of Contents
SCANSOURCE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In thousands)

| Nine months ended
| March 31,
| 2025 |  | 2024
Cash flows from operating activities: |  |  |
Net income | $ | 51,458 |  |  | $ | 60,964 |
Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
Gain on sale of business | — |  |  | (14,533) |
Depreciation and amortization | 23,095 |  |  | 21,217 |
Amortization of debt issue costs | 289 |  |  | 289 |
Provision for doubtful accounts | 7,699 |  |  | 5,863 |
Share-based compensation | 8,388 |  |  | 7,729 |
Deferred income taxes | 1,938 |  |  | (1,565) |
Change in fair value of contingent consideration | 2,047 |  |  | — |
Finance lease interest | 69 |  |  | 70 |
Changes in operating assets and liabilities: |  |  |
Accounts receivable | 13,441 |  |  | 143,774 |
Inventories | 34,576 |  |  | 226,878 |
Prepaid expenses and other assets | 8,013 |  |  | (28,163) |
Other non-current assets | 4,344 |  |  | 6,022 |
Accounts payable | (50,359) |  |  | (117,860) |
Accrued expenses and other liabilities | (5,632) |  |  | 11,338 |
Income taxes payable | 5,338 |  |  | (5,115) |
Net cash provided by operating activities | 104,704 |  |  | 316,908 |
Cash flows from investing activities: |  |  |
Capital expenditures | (5,769) |  |  | (7,285) |
Cash paid for business acquisitions, net of cash acquired | (56,673) |  |  | — |
Proceeds from sale of business, net of cash transferred | 2,569 |  |  | 17,978 |
Net cash (used in) provided by investing activities | (59,873) |  |  | 10,693 |
Cash flows from financing activities: |  |  |
Borrowings on revolving credit | 38,336 |  |  | 1,242,915 |
Repayments on revolving credit | (38,386) |  |  | (1,421,895) |
Repayments on long-term debt | (5,982) |  |  | (5,040) |
Repayments on finance lease obligation | (818) |  |  | (585) |
Exercise of stock options | 9,504 |  |  | 4,626 |
Taxes paid on settlement of equity awards | (4,819) |  |  | (2,794) |
Common stock repurchased, including excise tax | (81,259) |  |  | (21,168) |
Net cash used in financing activities | (83,424) |  |  | (203,941) |
Effect of exchange rate changes on cash and cash equivalents | (580) |  |  | (788) |
(Decrease) increase in cash and cash equivalents | (39,173) |  |  | 122,872 |
Cash and cash equivalents at beginning of period | 185,460 |  |  | 36,178 |
Cash and cash equivalents at end of period | $ | 146,287 |  |  | $ | 159,050 |
See accompanying notes to these condensed consolidated financial statements.

10

Table of Contents
SCANSOURCE, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
(1) Business and Summary of Significant Accounting Policies
Business Description
ScanSource, Inc. (together with its subsidiaries referred to as “the Company” or “ScanSource”) is a leading hybrid distributor connecting devices to the cloud and accelerating growth for channel partners across hardware, software as a service ("SaaS"), and connectivity and cloud services. ScanSource uses multiple sales models to offer hybrid distribution solutions from leading suppliers of specialty technologies and connectivity and cloud services. The Company operates in the United States, Canada and Brazil. The Company's two operating segments, Specialty Technology Solutions and Intelisys & Advisory, represent the different sales models the Company uses in executing its hybrid distribution growth strategy.
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements of the Company have been prepared by the Company’s management in accordance with United States generally accepted accounting principles ("U.S. GAAP") for interim financial information and applicable rules and regulations of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for annual financial statements. The unaudited condensed consolidated financial statements included herein contain all adjustments (consisting of normal recurring and non-recurring adjustments) that are, in the opinion of management, necessary to present fairly the financial position at March 31, 2025 and June 30, 2024, the results of operations for the quarters and nine months ended March 31, 2025 and 2024, the condensed consolidated statements of comprehensive income for the quarters and nine months ended March 31, 2025 and 2024, the condensed consolidated statements of shareholders' equity for the quarters and nine months ended March 31, 2025 and 2024 and the condensed consolidated statements of cash flows for the nine months ended March 31, 2025 and 2024. The results of operations for the quarter and nine months ended March 31, 2025 are not necessarily indicative of the results to be expected for a full year. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024. Unless otherwise indicated, disclosures provided in the notes to the Company's consolidated financial statements pertain to continuing operations only.
Segment Changes
Effective July 1, 2024, the Company realigned its operating segments to represent the different sales models it uses in executing its hybrid distribution growth strategy. The two realigned segments are Specialty Technology Solutions and Intelisys & Advisory. The Specialty Technology Solutions segment combines the Company's former segments, with the exception of the Company's Intelisys business. The Intelisys & Advisory segment includes the Intelisys and technology advisors businesses, including Channel Exchange (formerly known as intY USA), RPM and Resourcive. Both segments include recurring revenue.
The Company has reclassified certain prior-year amounts in the segment results to conform with the current year presentation. These reclassifications had no effect on the condensed consolidated financial results. See Note 10 - Segment Information for descriptions of the Company's segments.
Summary of Significant Accounting Policies
There have been no material changes to the Company’s significant accounting policies for the nine months ended March 31, 2025 from the policies described in the notes to the Company’s consolidated financial statements included in the Annual Report on Form 10-K for the fiscal year ended June 30, 2024. For a discussion of the Company’s significant accounting policies, please see the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024.
11

Table of Contents
Cash and Cash Equivalents
The Company considers all highly-liquid investments with original maturities of three months or less, when purchased, to be cash equivalents. The Company maintains zero-balance disbursement accounts at various financial institutions at which the Company does not maintain significant depository relationships. Due to the terms of the agreements governing these accounts, the Company generally does not have the right to offset outstanding checks written from these accounts against cash on hand, and the respective institutions are not legally obligated to honor the checks until sufficient funds are transferred to fund the checks. As a result, checks released but not yet cleared from these accounts in the amount of $0.2 million and $5.9 million are included in accounts payable on the condensed consolidated balance sheets at March 31, 2025 and June 30, 2024, respectively.
Long-lived Assets
The Company presents depreciation expense and intangible amortization expense on the condensed consolidated income statements. The Company's depreciation expense related to selling, general and administrative costs totaled $2.3 million and $8.1 million for the quarter and nine months ended March 31, 2025, respectively, and $2.7 million and $8.4 million for the quarter and nine months ended March 31, 2024, respectively. Depreciation expense reported as part of cost of goods sold on the condensed consolidated income statements totaled $0.2 million and $0.7 million for the quarter and nine months ended March 31, 2025, respectively, and $0.3 million and $0.8 million for the quarter and nine months ended March 31, 2024, respectively. The Company's intangible amortization expense reported on the condensed consolidated income statements relates to selling, general and administrative costs, not the cost of selling goods. Intangible amortization expense totaled $4.9 million and $14.3 million for the quarter and nine months ended March 31, 2025, respectively, and $3.8 million and $12.0 million for the quarter and nine months ended March 31, 2024, respectively.
Recent Accounting Pronouncements
In November 2023, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2023-07 “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” This ASU expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. This ASU is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. This ASU is applicable to the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2025, and subsequent interim periods, with early application permitted. The Company is currently evaluating the impact of the application of this ASU on its consolidated financial statements and disclosures.
In December 2023, the FASB issued ASU No. 2023-09 “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU updates income tax disclosure requirements primarily by requiring specific categories and greater disaggregation within the rate reconciliation and disaggregation of income taxes paid by jurisdiction. This ASU is effective for annual periods beginning after December 15, 2024 and is applicable to the Company’s fiscal year beginning July 1, 2025, with early application permitted. The Company is currently evaluating the impact of the application of this ASU on its consolidated financial statements and disclosures.
In November 2024, the FASB issued ASU 2024-03 "Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses." This ASU requires public entities to disclose specified information about certain costs and expenses. The ASU is effective for annual periods beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2028. This ASU is applicable to the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2027, and subsequent interim periods, with early application permitted. The Company is currently evaluating the impact of the application of this ASU on its consolidated financial statements and disclosures.
The Company has reviewed other newly issued accounting pronouncements and concluded that they are either not applicable to its business or that no material effect is expected on its consolidated financial statements as a result of future adoption.
(2) Trade Accounts and Notes Receivable, Net
The Company maintains an allowance for doubtful accounts receivable for estimated future expected credit losses resulting from customers’ failure to make payments on accounts receivable due to the Company. The Company has notes receivable with certain customers, which are included in “Accounts receivable, less allowance” in the Condensed Consolidated Balance Sheets.
12

Table of Contents
Management determines the estimate of the allowance for doubtful accounts receivable by considering a number of factors, including: (i) historical experience, (ii) aging of the accounts receivable, (iii) specific information obtained by the Company on the financial condition and the current creditworthiness of its customers, (iv) the current economic and country-specific environment and (v) reasonable and supportable forecasts about collectability. Expected credit losses are estimated on a pool basis when similar risk characteristics exist using an age-based reserve model. Receivables that do not share risk characteristics are evaluated on an individual basis. Estimates of expected credit losses on trade receivables over the contractual life are recorded at inception and adjusted over the contractual life.
The changes in the allowance for doubtful accounts for the nine months ended March 31, 2025 are set forth in the table below.

| June 30, 2024 |  | Amounts Charged to Expense |  | Write-offs |  | Other (1) |  | March 31, 2025
| (in thousands)
Trade accounts and current notes receivable allowance | $ | 20,684 |  |  | $ | 7,699 |  |  | $ | (1,127) |  |  | $ | (224) |  |  | $ | 27,032 |

(1)"Other" amounts include recoveries and the effect of foreign currency fluctuations for the nine months ended March 31, 2025.
(3) Revenue Recognition
The Company uses multiple sales models to offer hybrid distribution solutions from leading suppliers of specialty technologies and connectivity and cloud services. This includes hardware, related accessories and device configuration as well as software licenses, professional services and hardware support programs.
In determining the appropriate amount of revenue to recognize, the Company applies the following five-step model in accordance with ASC 606: (i) identify contracts with customers; (ii) identify performance obligations in the contracts; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations per the contracts; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company recognizes revenue as control of products and services are transferred to customers, which is generally at the point of shipment. The Company delivers products to customers in several ways, including: (i) shipment from a Company warehouse, (ii) drop-shipment directly from the supplier, or (iii) electronic delivery for non-physical products.
Principal versus Agent Considerations
The Company is the principal for sales of all hardware and certain software and services. The Company considers itself the principal in those transactions where it has control of the product or service before it is transferred to the customer. The Company recognizes the principal-associated revenue and cost of goods sold on a gross basis.
The Company is the agent for third-party service contracts, including product warranties and supplier-hosted software. These service contracts are sold separately from the products, and the Company often serves as the agent for the contract on behalf of the original equipment manufacturer. The Company's responsibility is to arrange for the provision of the specified service by the original equipment manufacturer, and the Company does not control the specified service before it is transferred to the customer. Because the Company acts as an agent, revenue is recognized net of cost at the time of sale. The Intelisys business operates under an agency model.
Variable Considerations
For certain transactions, products are sold with a right of return and may also provide other rebates or incentives, which are accounted for as variable consideration. The Company estimates a returns allowance based on historical experience and reduces revenue accordingly. The Company estimates the amount of variable consideration for rebates and incentives by using the expected value to be given to the customer and reduces the revenue by those estimated amounts. These estimates are reviewed and updated as necessary at the end of each reporting period.
Contract Balances
The Company records contract assets and liabilities for payments received from customers in advance of services performed. These assets and liabilities are the result of the sales of the Company's self-branded warranty programs and other transactions
13

Table of Contents
where control has not yet passed to the customer. These amounts are immaterial to the consolidated financial statements for the periods presented.
Disaggregation of Revenue
The following tables represent the Company's disaggregation of revenue:

|  | Quarter ended March 31, 2025 |  |
|  | Specialty Technology Solutions |  | Intelisys & Advisory |  | Total |  |  |  |
|  |  |  | (in thousands) |  |  |  |  |  |
Revenue by product/service |  |  |  |  |  |  |  |  |  |
Products and services |  | $ | 664,365 |  |  | $ | 864 |  |  | $ | 665,229 |  |  |  |  |
Recurring revenue(a) |  | 14,068 |  |  | 25,550 |  |  | 39,618 |  |  |  |  |
|  | $ | 678,433 |  |  | $ | 26,414 |  |  | $ | 704,847 |  |  |  |  |
|  | Nine months ended March 31, 2025 |  |
|  | Specialty Technology Solutions |  | Intelisys & Advisory |  | Total |  |  |  |
|  |  |  | (in thousands) |  |  |  |  |  |
Revenue by product/service: |  |  |  |  |  |  |  |  |  |
Products and services |  | $ | 2,115,958 |  |  | $ | 2,074 |  |  | $ | 2,118,032 |  |  |  |  |
Recurring revenue(a) |  | 38,051 |  |  | 71,841 |  |  | 109,892 |  |  |  |  |
|  | $ | 2,154,009 |  |  | $ | 73,915 |  |  | $ | 2,227,924 |  |  |  |  |
(a) Recurring revenue represents revenue primarily from agency commissions, SaaS, subscriptions, and hardware rentals. |  |  |  |

|  | Quarter ended March 31, 2024 |  |
|  | Specialty Technology Solutions |  | Intelisys & Advisory |  | Total |  |  |  |
|  |  |  | (in thousands) |  |  |  |  |  |
Revenue by product/service |  |  |  |  |  |  |  |  |  |
Products and services |  | $ | 723,597 |  |  | $ | 908 |  |  | $ | 724,505 |  |  |  |  |
Recurring revenue(a) |  | 6,237 |  |  | 21,857 |  |  | 28,094 |  |  |  |  |
|  | $ | 729,834 |  |  | $ | 22,765 |  |  | $ | 752,599 |  |  |  |  |
|  | Nine months ended March 31, 2024 |  |
|  | Specialty Technology Solutions |  | Intelisys & Advisory |  | Total |  |  |  |
|  |  |  | (in thousands) |  |  |  |  |  |
Revenue by product/service: |  |  |  |  |  |  |  |  |  |
Products and services |  | $ | 2,426,547 |  |  | $ | 2,784 |  |  | $ | 2,429,331 |  |  |  |  |
Recurring revenue(a) |  | 18,751 |  |  | 65,614 |  |  | 84,365 |  |  |  |  |
|  | $ | 2,445,298 |  |  | $ | 68,398 |  |  | $ | 2,513,696 |  |  |  |  |
(a) Recurring revenue represents revenue primarily from agency commissions, SaaS, subscriptions, and hardware rentals. |  |  |  |

(4) Earnings Per Share
14

Table of Contents
Basic earnings per share are computed by dividing net income by the weighted-average number of common shares outstanding. Diluted earnings per share are computed by dividing net income by the weighted-average number of common and potential common shares outstanding.

| Quarter ended |  | Nine months ended
| March 31, |  | March 31,
| 2025 |  | 2024 |  | 2025 |  | 2024
| (in thousands, except per share data)
Numerator: |  |  |  |  |  |  |
Net income | $ | 17,431 |  |  | $ | 12,806 |  |  | $ | 51,458 |  |  | $ | 60,964 |
Denominator: |  |  |  |  |  |  |
Weighted-average shares, basic | 23,275 |  |  | 25,025 |  |  | 23,746 |  |  | 24,982 |
Dilutive effect of share-based payments | 329 |  |  | 412 |  |  | 419 |  |  | 309 |
Weighted-average shares, diluted | 23,604 |  |  | 25,437 |  |  | 24,165 |  |  | 25,291 |
Net income per common share, basic | $ | 0.75 |  |  | $ | 0.51 |  |  | $ | 2.17 |  |  | $ | 2.44 |
Net income per common share, diluted | $ | 0.74 |  |  | $ | 0.50 |  |  | $ | 2.13 |  |  | $ | 2.41 |

For the quarter and nine months ended March 31, 2025, weighted-average shares outstanding excluded from the computation of diluted earnings per share because their effect would be anti-dilutive were 241,641 and 245,303, respectively. For the quarter and nine months ended March 31, 2024, weighted-average shares outstanding excluded from the computation of diluted earnings per share because their effect would be anti-dilutive were 164,093 and 755,797, respectively.
(5) Accumulated Other Comprehensive Loss
The components of accumulated other comprehensive loss, net of tax are as follows:

| March 31, 2025 |  | June 30, 2024
| (in thousands)
Foreign currency translation adjustment | $ | (122,441) |  |  | $ | (117,885) |
Unrealized gain on hedged transaction, net of tax | 788 |  |  | 2,032 |
Accumulated other comprehensive loss | $ | (121,653) |  |  | $ | (115,853) |

The tax effect of amounts in comprehensive loss reflect a tax (benefit) expense as follows:

| Quarter ended March 31, |  | Nine months ended March 31,
| 2025 |  | 2024 |  | 2025 |  | 2024
| (in thousands)
Tax (benefit) expense | $ | (146) |  |  | $ | 136 |  |  | $ | (352) |  |  | $ | (555) |

(6) Goodwill and Other Identifiable Intangible Assets
The changes in the carrying amount of goodwill for the nine months ended March 31, 2025, by reporting segment, are set forth in the table below.
15

Table of Contents

| Specialty Technology Solutions |  | Intelisys & Advisory |  | Total
| (in thousands)
Balance at June 30, 2024 | $ | 146,108 |  |  | $ | 60,193 |  |  | $ | 206,301 |
Additions | 13,442 |  |  | 9,334 |  |  | 22,776 |
Foreign currency translation adjustment | (382) |  |  | 140 |  |  | (242) |
Balance at March 31, 2025 | $ | 159,168 |  |  | $ | 69,667 |  |  | $ | 228,835 |

The following table shows changes in the amount recognized for net identifiable intangible assets for the nine months ended March 31, 2025.

| Net Identifiable Intangible Assets |
| (in thousands) |
Balance at June 30, 2024 | $ | 37,634 |  |
Additions | 44,500 |  |
Amortization expense | (14,300) |  |
Foreign currency translation adjustment | (19) |  |
Balance at March 31, 2025 | $ | 67,815 |  |

(7) Short-Term Borrowings and Long-Term Debt
The following table presents the Company’s debt at March 31, 2025 and June 30, 2024.

| March 31, 2025 |  | June 30, 2024
| (in thousands)
Current portion of long-term debt | $ | 7,861 |  |  | $ | 7,857 |
Mississippi revenue bond, net of current portion | 2,663 |  |  | 3,024 |
Senior secured term loan facility, net of current portion | 127,500 |  |  | 133,125 |
Borrowings under revolving credit facility | — |  |  | 50 |
Total debt | $ | 138,024 |  |  | $ | 144,056 |

Credit Facility
The Company has a multi-currency senior secured credit facility (as amended, the "Amended Credit Agreement") with JPMorgan Chase Bank N.A., as administrative agent (the "Administrative Agent"), and a syndicate of banks (collectively the "Lenders"). On September 28, 2022, the Company amended and restated the Amended Credit Agreement, which includes (i) a five-year, $350 million multicurrency senior secured revolving credit facility and (ii) a five-year $150 million senior secured term loan facility. The Amended Credit Agreement extended the credit facility maturity date to September 28, 2027. In addition, pursuant to an “accordion feature,” the Company may increase its borrowing limit by up to an additional $250 million, subject to obtaining additional credit commitments from the lenders participating in the increase. The Amended Credit Agreement allows for the issuance of up to $50 million for letters of credit. Borrowings under the Amended Credit Agreement are guaranteed by substantially all of the domestic subsidiaries of the Company and secured by their assets. Under the terms of the revolving credit facility, the payment of cash dividends is restricted. The Company incurred debt issuance costs of $1.4 million in connection with the amendment and restatement of the Amended Credit Agreement. These costs were capitalized to other non-current assets on the Condensed Consolidated Balance Sheets and added to the unamortized debt issuance costs from the previous credit facility.
Loans denominated in U.S. dollars, other than swingline loans, bear interest at a rate per annum equal to, at the Company’s option, (i) the adjusted term Secured Overnight Financing Rate ("SOFR") or adjusted daily simple SOFR plus an additional margin ranging from 1.00% to 1.75% depending upon the Company’s ratio of (A) total consolidated debt less up to $30 million of unrestricted domestic cash to (B) trailing four-quarter consolidated EBITDA measured as of the end of the most recent year
16

Table of Contents
or quarter, as applicable, for which financial statements have been delivered to the Lenders (the “leverage ratio”); or (ii) the alternate base rate plus an additional margin ranging from 0% to 0.75%, depending upon the Company’s leverage ratio, plus, if applicable, certain mandatory costs. All swingline loans denominated in U.S. dollars bear interest based upon the adjusted daily simple SOFR plus an additional margin ranging from 1.00% to 1.75% depending upon the Company's leverage ratio, or such other rate as the Company and the applicable swingline lender may agree. The adjusted term SOFR and adjusted daily simple SOFR include a fixed credit adjustment of 0.10% over the applicable SOFR reference rate. Loans denominated in foreign currencies bear interest at a rate per annum equal to the applicable benchmark rate set forth in the Amended Credit Agreement plus an additional margin ranging from 1.00% to 1.75%, depending upon the Company’s leverage ratio plus, if applicable, certain mandatory costs.
During the quarter and nine months ended March 31, 2025, all of the Company's borrowings under the Amended Credit Agreement were U.S. dollar loans. The spread in effect as of March 31, 2025 was 1.00%, plus a 0.10% credit spread adjustment for SOFR-based loans and 0.00% for alternate base rate loans. The commitment fee rate in effect at March 31, 2025 was 0.15%. The effective interest rates for the term loan were 5.42% and 6.44% as of March 31, 2025 and June 30, 2024, respectively. The Amended Credit Agreement includes customary representations, warranties and affirmative and negative covenants, including financial covenants. Specifically, the Company’s Leverage Ratio must be less than or equal to 3.50 to 1.00 at all times. In addition, the Company’s Interest Coverage Ratio (as such term is defined in the Amended Credit Agreement) must be at least 3.00 to 1.00 at the end of each fiscal quarter. In the event of a default, customary remedies are available to the lenders, including acceleration and increased interest rates. The Company was in compliance with all covenants under the Amended Credit Agreement at March 31, 2025.
The average daily outstanding balance on the revolving credit facility, excluding the term loan facility, during the nine month periods ended March 31, 2025 and 2024 was $0.3 million and $94.6 million, respectively. There was $350.0 million and $349.9 million available for additional borrowings as of March 31, 2025 and June 30, 2024, respectively. The effective interest rates for the revolving line of credit were 5.45% and 6.44% as of March 31, 2025 and June 30, 2024, respectively. There were no letters of credit issued under the multi-currency revolving credit facility at March 31, 2025 or June 30, 2024.
Mississippi Revenue Bond
On August 1, 2007, the Company entered into an agreement with the State of Mississippi to provide financing for the acquisition and installation of certain equipment to be utilized at the Company’s Southaven, Mississippi warehouse, through the issuance of an industrial development revenue bond. The bond matures on September 1, 2032. The bond accrues interest at the one-month term SOFR plus an adjustment of 0.10% plus a spread of 0.85%. The agreement also provides the bondholder with a put option, exercisable only within 180 days of each fifth anniversary of the agreement, requiring the Company to pay back the bonds at 100% of the principal amount outstanding. At March 31, 2025, the Company was in compliance with all covenants under this bond. The interest rates at March 31, 2025 and June 30, 2024 were 5.27% and 6.28%, respectively.
Debt Issuance Costs
At March 31, 2025, net debt issuance costs associated with the credit facility and bond totaled $1.0 million and are being amortized on a straight-line basis through the maturity date of each respective debt instrument.
(8) Derivatives and Hedging Activities
The Company's results of operations could be materially impacted by significant changes in foreign currency exchange rates and interest rates. In an effort to manage the exposure to these risks, the Company periodically enters into various derivative instruments. The Company's accounting policies for these instruments are based on whether the instruments are designated as hedge or non-hedge instruments in accordance with U.S. GAAP. The Company records all derivatives on the Condensed Consolidated Balance Sheet at fair value. Derivatives that are not designated as hedging instruments or the ineffective portions of cash flow hedges are adjusted to fair value through earnings in other income and expense.
Foreign Currency Derivatives – The Company conducts a portion of its business internationally in a variety of foreign currencies and is exposed to market risk for changes in foreign currency exchange rates. The Company attempts to hedge transaction exposures with natural offsets to the fullest extent possible and once these opportunities have been exhausted the Company uses currency options and forward contracts or other hedging instruments with third parties. These contracts will periodically hedge the exchange of various currencies, including the U.S. dollar, Brazilian real, euro, British pound and Canadian dollar.
17

Table of Contents
The Company had contracts outstanding for purposes of managing cash flows with notional amounts of $27.2 million and $27.5 million for the exchange of foreign currencies at March 31, 2025 and June 30, 2024, respectively. To date, the Company has chosen not to designate these derivatives as hedging instruments, and accordingly, these instruments are adjusted to fair value through earnings in other income and expense. Summarized financial information related to these derivative contracts and changes in the underlying value of the foreign currency exposures included in the Condensed Consolidated Income Statements for the quarters and nine months ended March 31, 2025 and 2024 are as follows:

| Quarter ended |  | Nine months ended
| March 31, |  | March 31,
| 2025 |  | 2024 |  | 2025 |  | 2024
| (in thousands)
Net foreign exchange derivative contract losses (gains) | $ | 1,446 |  |  | $ | (526) |  |  | $ | (31) |  |  | $ | 132 |
Net foreign currency transactional and re-measurement (gains) losses | (1,316) |  |  | 1,034 |  |  | 243 |  |  | 1,500 |
Net foreign currency exchange losses | $ | 130 |  |  | $ | 508 |  |  | $ | 212 |  |  | $ | 1,632 |

Net foreign currency exchange gains and losses consist of foreign currency transactional and functional currency re-measurements, offset by net foreign currency exchange contract gains and losses and are included in other income and expense. Foreign exchange gains and losses are primarily generated as the result of fluctuations in the value of the U.S. dollar versus the Brazilian real and the Canadian dollar versus the U.S. dollar.
Interest Rates - The Company’s earnings are also affected by changes in interest rates due to the impact those changes have on interest expense from floating rate debt instruments. The Company manages its exposure to changes in interest rates by using interest rate swaps to hedge this exposure and to achieve a desired proportion of fixed versus floating rate debt.
On April 30, 2019, the Company entered into an interest rate swap agreement to lock into a fixed LIBOR interest rate, which was amended on September 28, 2022, to change the reference rate from LIBOR to SOFR. The swap agreement has a notional amount of $100.0 million, with a $50.0 million tranche that matured on April 30, 2024 and a $50.0 million tranche scheduled to mature April 30, 2026.
On March 31, 2023, the Company entered into an interest rate swap agreement to lock into a fixed SOFR interest rate with a notional amount of $25.0 million and a maturity date of March 31, 2028.
These interest rate swap agreements are designated as cash flow hedges to hedge the variable rate interest payments on the revolving credit facility. Interest rate differentials paid or received under the swap agreements are recognized as adjustments to interest expense. To the extent the swaps are effective in offsetting the variability of the hedged cash flows, changes in the fair value of the swaps are not included in current earnings but are reported as other comprehensive income (loss). There was no ineffective portion to be recorded as an adjustment to earnings for the quarters and nine months ended March 31, 2025 and 2024.
The components of the cash flow hedge included in the Condensed Consolidated Statement of Comprehensive Income for the quarters and nine months ended March 31, 2025 and 2024, are as follows:

| Quarter ended |  | Nine months ended
| March 31, |  | March 31,
| 2025 |  | 2024 |  | 2025 |  | 2024
| (in thousands)
Net interest income recognized as a result of interest rate swap | $ | (315) |  |  | $ | (895) |  |  | $ | (1,214) |  |  | $ | (2,676) |
Unrealized (loss) gain in fair value of interest rate swap | (298) |  |  | 1,093 |  |  | (438) |  |  | 1,021 |
Net (decrease) increase in accumulated other comprehensive income | (613) |  |  | 198 |  |  | (1,652) |  |  | (1,655) |
Income tax effect | (151) |  |  | 50 |  |  | (407) |  |  | (409) |
Net (decrease) increase in accumulated other comprehensive income, net of tax | $ | (462) |  |  | $ | 148 |  |  | $ | (1,245) |  |  | $ | (1,246) |

The Company used the following derivative instruments at March 31, 2025 and June 30, 2024, reflected in its Condensed Consolidated Balance Sheets, for the risk management purposes detailed above:
18

Table of Contents

|  |  | March 31, 2025 |  | June 30, 2024
| Balance Sheet Location |  | Fair Value of Derivatives Designated as Hedge Instruments |  | Fair Value of Derivatives Not Designated as Hedge Instruments |  | Fair Value of Derivatives Designated as Hedge Instruments |  | Fair Value of Derivatives Not Designated as Hedge Instruments
|  |  | (in thousands)
Derivative assets: |  |  |  |  |  |  |  |  |
Forward foreign currency exchange contracts | Prepaid expenses and other current assets |  | — |  |  | $ | 17 |  |  | — |  |  | — |
Foreign currency hedge | Prepaid expenses and other current assets |  | $ | 16 |  |  | $ | — |  |  | $ | 345 |  |  | $ | — |
Interest rate swap agreement | Other non-current assets |  | $ | 1,046 |  |  | $ | — |  |  | $ | 2,698 |  |  | $ | — |
Derivative liabilities: |  |  |  |  |  |  |  |  |
Forward foreign currency exchange contracts | Accrued expenses and other current liabilities |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 12 |

19

Table of Contents
(9) Fair Value of Financial Instruments
Accounting guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Under this guidance, the Company classifies certain assets and liabilities based on the fair value hierarchy, which aggregates fair value measured assets and liabilities based upon the following levels of inputs:
•Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;
•Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and
•Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).
The assets and liabilities maintained by the Company that are required to be measured at fair value on a recurring basis include deferred compensation plan investments, forward foreign currency exchange contracts, foreign currency hedge agreements, interest rate swap agreements and contingent consideration owed to the sellers of Advantix Solutions Group, Inc ("Advantix") and Secure Path Networks, LLC dba Resourcive ("Resourcive"). The carrying value of debt is considered to approximate fair value, as the Company’s debt instruments are indexed to a variable rate using the market approach (Level 2).
The following table summarizes the valuation of the Company’s remaining assets and liabilities measured at fair value on a recurring basis at March 31, 2025:

| Total |  | Quoted prices in active markets (Level 1) |  | Significant other observable inputs (Level 2) |  | Significant unobservable inputs (Level 3)
| (in thousands)
Assets: |  |  |  |  |  |  |
Deferred compensation plan investments, current and non-current | $ | 30,110 |  |  | $ | 30,110 |  |  | $ | — |  |  | $ | — |
Forward foreign currency exchange contracts | 17 |  |  | — |  |  | 17 |  |  | — |
Interest rate swap agreement | 1,046 |  |  | — |  |  | 1,046 |  |  | — |
Foreign currency hedge | 16 |  |  | — |  |  | 16 |  |  | — |
Total assets at fair value | $ | 31,189 |  |  | $ | 30,110 |  |  | $ | 1,079 |  |  | $ | — |
Liabilities: |  |  |  |  |  |  |
Deferred compensation plan investments, current and non-current | $ | 30,110 |  |  | $ | 30,110 |  |  | $ | — |  |  | $ | — |
Liability for contingent consideration, current and non-current | 19,247 |  |  | — |  |  | — |  |  | 19,247 |
Total liabilities at fair value | $ | 49,357 |  |  | $ | 30,110 |  |  | $ | — |  |  | $ | 19,247 |

The following table summarizes the valuation of the Company’s remaining assets and liabilities measured at fair value on a recurring basis at June 30, 2024:
20

Table of Contents

| Total |  | Quoted prices in active markets (Level 1) |  | Significant other observable inputs (Level 2) |  | Significant unobservable inputs (Level 3)
| (in thousands)
Assets: |  |  |  |  |  |  |
Deferred compensation plan investments, current and non-current | $ | 31,014 |  |  | $ | 31,014 |  |  | $ | — |  |  | $ | — |
Interest rate swap agreement | 2,698 |  |  | — |  |  | 2,698 |  |  | — |
Foreign currency hedge | 345 |  |  | — |  |  | 345 |  |  | — |
Total assets at fair value | $ | 34,057 |  |  | $ | 31,014 |  |  | $ | 3,043 |  |  | $ | — |
Liabilities: |  |  |  |  |  |  |
Deferred compensation plan investments, current and non-current | $ | 31,014 |  |  | $ | 31,014 |  |  | $ | — |  |  | $ | — |
Forward foreign currency exchange contracts | 12 |  |  | — |  |  | 12 |  |  | — |
Total liabilities at fair value | $ | 31,026 |  |  | $ | 31,014 |  |  | $ | 12 |  |  | $ | — |

The investments in the deferred compensation plan are held in a "rabbi trust" and include securities and cash equivalents for payment of non-qualified benefits for certain retired, terminated and active employees. These investments are recorded to prepaid expenses and other current assets or other non-current assets depending on their corresponding, anticipated distribution dates to recipients, which are reported in accrued expenses and other current liabilities or other long-term liabilities, respectively.
Derivative instruments, such as foreign currency forward contracts, are measured using the market approach on a recurring basis considering foreign currency spot rates and forward rates quoted by banks or foreign currency dealers and interest rates quoted by banks (Level 2). Fair values of interest rate swaps are measured using standard valuation models with inputs that can be derived from observable market transactions, including SOFR spot and forward rates (Level 2). Foreign currency contracts and interest rate swap agreements are classified in the Condensed Consolidated Balance Sheets as prepaid expenses and other non-current assets or accrued expenses and other long-term liabilities, depending on the respective instruments' favorable or unfavorable positions. See Note 8 - Derivatives and Hedging Activities.
The Company recorded a contingent consideration liability at the acquisition date of both Advantix and Resourcive. These liabilities represent the amounts payable to sellers, as outlined under the terms of the asset purchase agreements, based upon the achievement of a projected earnings before interest expense, taxes, depreciation and amortization, net of specific pro forma adjustments.
The following tables represent the Company's contingent consideration liabilities at fair value at March 31, 2025:

| Quarter ended March 31, 2025 |  |
| Specialty Technology Solutions |  | Intelisys & Advisory |  | Total |  |  |  |  |  |
| (in thousands)
Fair value at beginning of period | $ | 7,973 |  |  | $ | 10,370 |  |  | $ | 18,343 |  |  |  |  |  |  |
Change in fair value of contingent consideration | 94 |  |  | 810 |  |  | 904 |  |  |  |  |  |  |
Fair value at end of period | $ | 8,067 |  |  | $ | 11,180 |  |  | $ | 19,247 |  |  |  |  |  |  |
| Nine months ended March 31, 2025 |  |  |  |  |  |
| Specialty Technology Solutions |  | Intelisys & Advisory |  | Total |  |  |  |  |  |
| (in thousands)
Fair value at beginning of period | $ | — |  |  | $ | — |  |  | $ | — |  |  |  |  |  |  |
Issuance of contingent consideration | 7,500 |  |  | 9,700 |  |  | 17,200 |  |  |  |  |  |  |
Change in fair value of contingent consideration | 567 |  |  | 1,480 |  |  | 2,047 |  |  |  |  |  |  |
Fair value at end of period | $ | 8,067 |  |  | $ | 11,180 |  |  | $ | 19,247 |  |  |  |  |  |  |

21

Table of Contents

The fair values of amounts owed are recorded in current portion of contingent consideration and long-term portion of contingent consideration in the Company’s Condensed Consolidated Balance Sheets. In accordance with ASC 805, the Company will revalue the contingent consideration liability at each reporting date through the last payment, with changes in the fair value of the contingent consideration reflected in the change in fair value of contingent consideration line item on the Company’s Condensed Consolidated Income Statements that is included in the calculation of operating income. The fair value of the contingent consideration liability associated with future earnout payments is based on several factors, including but not limited to:
•estimated future results, net of pro forma adjustments set forth in the purchase agreements;
•a risk premium reflective of the Company’s creditworthiness and market risk premium associated with the United States markets.
Advantix
Advantix is part of the Specialty Technology Solutions segment. The fair value of the contingent consideration is determined using a static discounted cash flow model. The fair value of the liability for the contingent consideration related to Advantix recognized at March 31, 2025 was $8.1 million, of which $1.7 million is classified as current. The change in fair value for the quarter and nine months ended March 31, 2025 is primarily due to the recurring amortization of the unrecognized fair value discount. Earnout payments to the sellers of Advantix are payable based on results from fiscal year 2025 to fiscal year 2028.
Resourcive
Resourcive is part of the Intelisys & Advisory segment. The fair value of the contingent consideration for Resourcive is determined using a Monte Carlo simulation. The fair value of the liability for the contingent consideration related to Resourcive recognized at March 31, 2025 was $11.2 million, all of which is classified as non-current and is due to the sellers of Resourcive during fiscal year 2027. The change in fair value for the quarter and nine months ended March 31, 2025 is primarily due to the recurring amortization of the unrecognized fair value discount.
Valuation techniques and significant observable inputs used in recurring Level 3 fair value measurements for the Company's contingent consideration liabilities related to Advantix and Resourcive at March 31, 2025 were as follows.

Acquisition |  | Reporting Period |  | Valuation Technique |  | Significant Unobservable Inputs |  | Weighted Average Rates
Advantix |  | March 31, 2025 |  | Discounted cash flow |  | Adjusted EBITDA risk premium |  | 15.0 | %
|  |  |  |  |  | Adjusted EBITDA growth rate |  | 28.1 | %
Resourcive |  | March 31, 2025 |  | Monte Carlo |  | Adjusted EBITDA risk premium |  | 12.9 | %
|  |  |  |  |  | Simulated commission growth percentage |  | 15.2 | %

(10) Segment Information
The Company is a leading provider of technology solutions and services to customers in specialty technology markets. The Company has two reportable segments based on sales model.
Specialty Technology Solutions Segment
The Specialty Technology Solutions segment operates in the United States, Canada and Brazil and includes specialty technology solutions distributed through a wholesale sales model. This segment includes hardware, SAAS and subscription services. The specialty technology solutions include the following:
•Mobility and barcode solutions - mobile computing, barcode scanners and imagers, radio frequency identification devices, barcode printing and related services;
•Point-of-Sale "POS" and payments solutions - POS systems, integrated POS software platforms, self-service kiosks including self-checkout, payment terminals and mobile payment devices;
•Security solutions - video surveillance and analytics, video management software and access control;
•Networking solutions - switching, routing and wireless products and software; and
•Communications and collaboration solutions - voice, video, communication platform integration and contact center solutions.
22

Table of Contents
•Connectivity - managed connectivity and wireless enablement solutions.
Intelisys & Advisory Segment
The Intelisys & Advisory segment operates in the United States and distributes connectivity and cloud services through an agency sales model. The connectivity and cloud services include telecom, cable, Unified Communications as a Service ("UCaaS"), Contact Center as a Service ("CCaaS"), Infrastructure as a Service ("IaaS"), Software-Defined Wide-Area Network ("SD-WAN") and other cloud services. This segment includes SaaS and subscription services, which the Company offers using digital tools and platforms.
Selected financial information for each business segment is presented below:

| Quarter ended |  | Nine months ended |  |
| March 31, |  | March 31, |  |
| 2025 |  | 2024 |  | 2025 |  | 2024 |  |
| (in thousands) |  |
Sales: |  |  |  |  |  |  |  |  |
Specialty Technology Solutions | $ | 678,433 |  |  | $ | 729,834 |  |  | $ | 2,154,009 |  |  | $ | 2,445,298 |  |  |
Intelisys & Advisory | 26,414 |  |  | 22,765 |  |  | 73,915 |  |  | 68,398 |  |  |
| $ | 704,847 |  |  | $ | 752,599 |  |  | $ | 2,227,924 |  |  | $ | 2,513,696 |  |  |
Depreciation and amortization: |  |  |  |  |  |  |  |  |
Specialty Technology Solutions | $ | 5,016 |  |  | $ | 3,958 |  |  | $ | 14,759 |  |  | $ | 13,034 |  |  |
Intelisys & Advisory | 2,227 |  |  | 2,065 |  |  | 6,650 |  |  | 5,977 |  |  |
Corporate | 248 |  |  | 719 |  |  | 1,686 |  |  | 2,206 |  |  |
| $ | 7,491 |  |  | $ | 6,742 |  |  | $ | 23,095 |  |  | $ | 21,217 |  |  |
Change in fair value of contingent consideration: |  |  |  |  |  |  |  |  |
Specialty Technology Solutions | $ | 94 |  |  | $ | — |  |  | $ | 567 |  |  | $ | — |  |  |
Intelisys & Advisory | 810 |  |  | — |  |  | 1,480 |  |  | — |  |  |
| $ | 904 |  |  | $ | — |  |  | $ | 2,047 |  |  | $ | — |  |  |
Operating income (loss): |  |  |  |  |  |  |  |  |
Specialty Technology Solutions | $ | 14,294 |  |  | $ | 14,580 |  |  | $ | 45,110 |  |  | $ | 51,914 |  |  |
Intelisys & Advisory | 8,320 |  |  | 7,489 |  |  | 21,173 |  |  | 22,411 |  |  |
Corporate (a) | (275) |  |  | (4,527) |  |  | (7,870) |  |  | (5,871) |  |  |
| $ | 22,339 |  |  | $ | 17,542 |  |  | $ | 58,413 |  |  | $ | 68,454 |  |  |
Capital expenditures: |  |  |  |  |  |  |  |  |
Specialty Technology Solutions | $ | (1,329) |  |  | $ | (2,384) |  |  | $ | (5,423) |  |  | $ | (7,220) |  |  |
Intelisys & Advisory | (91) |  |  | (36) |  |  | (346) |  |  | (65) |  |  |
| $ | (1,420) |  |  | $ | (2,420) |  |  | $ | (5,769) |  |  | $ | (7,285) |  |  |
Sales by Geography Category: |  |  |  |  |  |  |  |  |
United States and Canada | $ | 657,598 |  |  | $ | 672,662 |  |  | $ | 2,063,467 |  |  | $ | 2,262,707 |  |  |
Brazil(b) | 47,883 |  |  | 81,353 |  |  | 171,830 |  |  | 256,067 |  |  |
Less intercompany sales | (634) |  |  | (1,416) |  |  | (7,373) |  |  | (5,078) |  |  |
| $ | 704,847 |  |  | $ | 752,599 |  |  | $ | 2,227,924 |  |  | $ | 2,513,696 |  |  |
(a) For the quarter and nine months ended March 31, 2025, the amounts shown above include restructuring expense, acquisition and divestiture, cyberattack restoration costs as well as legal settlement. For the quarter and nine months ended March 31, 2024, the amounts above include acquisition and divestiture costs as well as cyberattack restoration costs. |  |
(b) Countries outside of Brazil represent $0.1 million, or 0.2% of sales, and $0.3 million or 0.2% of sales, for the quarter and nine months ended March 31, 2025. Countries outside of Brazil represent $0.1 million, or 0.2% of sales, and $4.3 million, or 1.7% of sales, for the quarter and nine months ended March 31, 2024. |  |

23

Table of Contents

| March 31, 2025 |  | June 30, 2024
| (in thousands)
Assets: |  |  |
Specialty Technology Solutions | $ | 1,497,108 |  |  | $ | 1,499,146 |
Intelisys & Advisory | 228,100 |  |  | 279,886 |
| $ | 1,725,208 |  |  | $ | 1,779,032 |
Property and equipment, net by Geography Category: |  |  |
United States and Canada | $ | 16,246 |  |  | $ | 21,613 |
Brazil | 13,751 |  |  | 11,888 |
| $ | 29,997 |  |  | $ | 33,501 |

(11) Leases
In accordance with Accounting Standards Codification ("ASC") 842, at contract inception the Company determines if a contract contains a lease by assessing whether the contract contains an identified asset and whether the Company has the ability to control the asset. The Company also determines if the lease meets the classification criteria for an operating lease versus a finance lease under ASC 842. Substantially all of the Company's leases are operating leases for real estate, warehouse and office equipment ranging in duration from 1 year to 10 years. The Company has elected not to record short-term operating leases with an initial term of 12 months or less on the Condensed Consolidated Balance Sheets. Operating leases are recorded as other non-current assets, accrued expenses and other current liabilities and other long-term liabilities on the Condensed Consolidated Balance Sheets. The Company has finance leases for information technology equipment expiring through fiscal year 2028. Finance leases are recorded as property and equipment, net, accrued expenses and other current liabilities and other long-term liabilities on the Condensed Consolidated Balance Sheets. The gross amount of the balances recorded related to finance leases is immaterial to the condensed consolidated financial statements at March 31, 2025 and the consolidated financial statements at June 30, 2024.
Operating lease right-of-use assets and lease liabilities are recognized at the commencement date based on the net present value of future minimum lease payments over the lease term. The Company generally is not able to determine the rate implicit in its leases and has elected to apply an incremental borrowing rate as the discount rate for the present value determination, which is based on the Company's cost of borrowings for the relevant terms of each lease and geographical economic factors. Certain operating lease agreements contain options to extend or terminate the lease. The lease term used is adjusted for these options when the Company is reasonably certain it will exercise the option. Operating lease expense is recognized on a straight-line basis over the lease term. Variable lease payments not based on a rate or index, such as costs for common area maintenance, are expensed as incurred. Further, the Company has elected the practical expedient under ASC 842 to recognize all lease and non-lease components as a single lease component, where applicable.
The following table presents amounts recorded on the Condensed Consolidated Balance Sheets related to operating leases at March 31, 2025 and June 30, 2024:

|  |  |  | March 31, 2025 |  | June 30, 2024
Operating leases |  | Balance Sheet location |  | (in thousands)
Operating lease right-of-use assets |  | Other non-current assets |  | $ | 11,155 |  |  | $ | 9,057 |
Current operating lease liabilities |  | Accrued expenses and other current liabilities |  | $ | 3,928 |  |  | $ | 3,398 |
Long-term operating lease liabilities |  | Other long-term liabilities |  | $ | 7,932 |  |  | $ | 6,507 |

The following table presents amounts recorded in operating lease expense as part of selling general and administrative expenses on the Condensed Consolidated Income Statements during the quarters and nine months ended March 31, 2025 and 2024. Operating lease costs contain immaterial amounts of short-term lease costs for leases with an initial term of 12 months or less.
24

Table of Contents

|  | Quarter ended March 31, |  | Nine months ended March 31,
|  | 2025 |  | 2024 |  | 2025 |  | 2024
|  | (in thousands)
Operating lease cost |  | $ | 1,113 |  |  | $ | 1,143 |  |  | $ | 3,329 |  |  | $ | 3,786 |
Variable lease cost |  | 398 |  |  | 364 |  |  | 1,072 |  |  | 1,069 |
|  | $ | 1,511 |  |  | $ | 1,507 |  |  | $ | 4,401 |  |  | $ | 4,855 |

Supplemental cash flow information related to the Company's operating leases for the nine months ended March 31, 2025 and 2024 are presented in the table below:

|  |  |  | Nine months ended March 31,
|  |  |  |  |  | 2025 |  | 2024
|  |  |  | (in thousands)
Cash paid for amounts in the measurement of lease liabilities |  |  |  |  |  | $ | 3,039 |  |  | $ | 4,019 |
Right-of-use assets obtained in exchange for lease obligations |  |  |  |  |  | 5,035 |  |  | 840 |

The weighted-average remaining lease term and discount rate at March 31, 2025 are presented in the table below:

|  | March 31, 2025
Weighted-average remaining lease term |  | 3.22 years
Weighted-average discount rate |  | 5.26 | %

The following table presents the maturities of the Company's operating lease liabilities at March 31, 2025:

|  | Operating leases
|  | (in thousands)
2025 |  | $ | 1,095 |
2026 |  | 4,418 |
2027 |  | 4,069 |
2028 |  | 1,690 |
2029 |  | 1,013 |
Thereafter |  | 603 |
Total future payments |  | 12,888 |
Less: amounts representing interest |  | 1,028 |
Present value of lease payments |  | $ | 11,860 |

(12) Commitments and Contingencies
The Company is, from time to time, party to lawsuits arising out of operations. Although there can be no assurance, based upon information known to the Company, the Company believes that any liability resulting from an adverse determination of such lawsuits would not have a material adverse effect on the Company’s financial condition, results of operations or cash flows.
During the Company's due diligence for the Network1 acquisition completed in 2016, several pre-acquisition contingencies were identified regarding various Brazilian federal and state tax exposures. The Company recorded indemnification receivables that are reported gross of the pre-acquisition contingency liabilities as the funds were escrowed as part of the acquisition. The amount available after the impact of foreign currency translation for future pre-acquisition contingency settlements or to be released to the sellers was $3.2 million at March 31, 2025 and June 30, 2024.
25

Table of Contents
The table below summarizes the balances and line item presentation of Network1's pre-acquisition contingencies and corresponding indemnification receivables in the Company's Condensed Consolidated Balance Sheets at March 31, 2025 and June 30, 2024:

| March 31, 2025 |  | June 30, 2024
| Network1
| (in thousands)
Assets |  |  |
Prepaid expenses and other current assets | $ | 14 |  |  | $ | 14 |
Other non-current assets | $ | 3,483 |  |  | $ | 3,598 |
Liabilities |  |  |
Accrued expenses and other current liabilities | $ | 14 |  |  | $ | 14 |
Other long-term liabilities | $ | 3,483 |  |  | $ | 3,598 |

(13) Income Taxes
Income taxes for the quarters and nine months ended March 31, 2025 and 2024 have been included in the accompanying condensed consolidated financial statements using an estimated annual effective tax rate. In addition to applying the estimated annual effective tax rate to pre-tax income, the Company includes certain items treated as discrete events to arrive at an estimated overall tax provision. During the quarter ended March 31, 2025, there were no material discrete items. During the quarter ended March 31, 2024, a discrete net tax benefit of $1.5 million was recorded, which is attributable to an income tax recovery in Brazil related to a prior period.
The Company’s effective tax rate of 28.0% and 23.1% for the quarter and nine months ended March 31, 2025, respectively, differs from the current federal statutory rate of 21% primarily as a result of income derived from tax jurisdictions with varying income tax rates, discrete items, nondeductible expenses and state income taxes. The Company's effective tax rate was 28.7% and 21.0% for the quarter and nine months ended March 31, 2024, respectively.
As of March 31, 2025, the Company is not permanently reinvested with respect to all earnings generated by foreign operations. The Company has determined that there is no material deferred tax liability for federal, state and withholding tax related to undistributed earnings. During the quarter ended March 31, 2025, foreign subsidiaries did not repatriate cash to the United States. There is no certainty to the timing of any future distributions of such earnings to the U.S. in whole or in part.
The Company had approximately $1.2 million and $1.1 million of total gross unrecognized tax benefits at March 31, 2025 and June 30, 2024, respectively. Of this total at March 31, 2025, approximately $0.9 million represents the amount of unrecognized tax benefits that are permanent in nature and, if recognized, would affect the annual effective tax rate. The Company does not believe that the total amount of unrecognized tax benefits will significantly increase or decrease within twelve months of the reporting date.
The Company’s policy is to recognize interest and penalties related to income tax matters in income tax expense. At March 31, 2025 and June 30, 2024, the Company had approximately $1.3 million accrued for interest and penalties.
The Company conducts business internationally and one or more of its subsidiaries files income tax returns in the U.S. federal, various state, local and foreign jurisdictions. In the normal course of business, the Company is subject to examination by taxing authorities in countries and states in which it operates. With certain exceptions, the Company is no longer subject to federal, state and local or non-U.S. income tax examinations by tax authorities for the years before June 30, 2019.
(14) Restructurings
In January 2024 and September 2024, as part of a strategic review of organizational structure and operations, the Company executed cost reduction and restructuring programs to align our cost structure with demand expectations in our business. The actions taken in January 2024 and September 2024 are expected to result in approximately $10.0 million and $10.5 million in annualized savings in selling, general and administrative expenses, respectively, most of which is expected to be realized during this fiscal year.
The following table presents the restructuring and employee separation costs incurred for the quarter and nine months ended March 31, 2025:
26

Table of Contents

| Quarter ended |  | Nine months ended |  |
| March 31, 2025 |  | March 31, 2025 |  |
| (in thousands) |  |
Employee separation and benefit costs | $ | — |  |  | 5,381 |  |  |

For the quarter and nine months ended March 31, 2025, all restructuring costs are recognized in the Corporate reporting unit and have not been allocated to the Specialty Technology Solutions or Intelisys & Advisory segments.
Accrued restructuring costs are included in accrued expenses and other current liabilities on the Condensed Consolidated Balance Sheets. The following table represents activity for the nine months ended March 31, 2025:

| Accrued Expenses |
| (in thousands) |
Balance at June 30, 2024 | $ | 1,629 |  |
Charged to expense | 5,381 |  |
Cash payments | (5,737) |  |
Balance at March 31, 2025 | $ | 1,273 |  |

The remaining balance as of March 31, 2025 of $1.3 million is expected to be paid through the third quarter of fiscal year 2026.
(15) Business Acquisitions
On August 8, 2024, ScanSource acquired substantially all of the assets of Resourcive, a leading technology advisor, through its subsidiary ScanSource Agency, Inc. Resourcive delivers strategic IT sourcing solutions to mid-market and enterprise businesses. On August 15, 2024, ScanSource acquired, through its subsidiary Advantix ScanSource, LLC, substantially all of the assets of Advantix, a managed connectivity experience provider specializing in wireless enablement solutions. The combined initial purchase price of these acquisitions, net of cash acquired, was approximately $56.7 million. The Advantix acquisition is included in the Specialty Technology Solutions segment, and the Resourcive acquisition is included in the Intelisys & Advisory segment. Both acquisitions included future earnout payments, and the Company recorded contingent consideration liabilities at the acquisition dates representing the fair value of estimated amounts payable to sellers. See Note 9 - Fair Value of Financial Instruments for the related disclosures regarding the contingent consideration liabilities recognized in connection with these acquisitions.
The purchase prices were allocated to the assets acquired and liabilities assumed based on their estimated fair values on the transaction dates. Intangible assets acquired include trade names, customer relationships, and developed technology. See Note 6 - Goodwill and Other Identifiable Intangible Assets for the amounts of goodwill and intangible assets recognized in connection with these acquisitions. The allocation of the purchase prices to the assets and liabilities acquired, including the valuation of the identifiable intangible assets, has not been concluded as of the reporting date. The impact of these acquisitions was not material to the consolidated financial statements. The Company recognized $0.2 million and $0.8 million for the quarter and nine months ended March 31, 2025, respectively, in acquisition-related costs included in selling, general and administrative expenses on the Condensed Consolidated Income Statements.
(16) Business Sale
On December 19, 2023, the Company completed the sale of its UK-based intY business. Under the stock purchase agreement, the Company received proceeds of $17.6 million in cash for the sale, net of cash transferred. The business sale resulted in a $14.2 million gain on sale after considering the net assets sold. During the quarter ended December 31, 2024, $2.6 million in cash was released from escrow related to the sale of intY. The impact of this sale was not material to the consolidated financial statements.

Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview
ScanSource is a leading hybrid distributor connecting devices to the cloud and accelerating growth for customers and channel partners across hardware, software as a service ("SaaS"), and connectivity and cloud services. ScanSource uses multiple sales
27

Table of Contents
models to offer hybrid distribution solutions from leading suppliers of specialty technologies and connectivity and cloud services. The Company operates in the United States, Canada and Brazil.
We operate our business under a management structure that enhances our specialty technology focus and hybrid distribution growth strategy. Our segments operate in the United States, Canada and Brazil and are based on sales models:
•Specialty Technology Solutions
•Intelisys & Advisory
We offer hardware, SaaS, and connectivity and cloud services from leading technology suppliers to customers and channel partners enabling solutions for users' needs and challenges. We operate distribution facilities that support our United States and Canada business in Mississippi, California and Kentucky. Brazil distribution facilities are located in the Brazilian states of Paraná, Espirito Santo and Santa Catarina. We provide some of our digital products, which include SaaS and subscriptions, through our digital tools and platforms.
Recent Developments
Impact of the Macroeconomic Environment, Including Growth Outlook, Inflation and Tariffs
The macroeconomic environment, including the economic impacts of growth outlook, inflation, tariffs and shifting relations between the U.S. and other countries, continues to create significant uncertainty and may adversely affect our financial condition and results of operations. In 2025, the U.S. announced a variety of additional tariffs on goods from multiple nations and trading blocks and has been targeted with reciprocal tariffs and other retaliatory actions in response. Although the U.S. has announced a 90-day pause on certain tariffs, negotiations and the state of international trade policy and relations continue to evolve. We are mindful of the potential impact these conditions could have on our customers, suppliers and end-customer demand and we are actively monitoring changes to the global macroeconomic environment and assessing the potential impacts these challenges may have on our financial condition, results of operations and liquidity. We expect to pass any price increases from our suppliers resulting from tariffs to our customers. We are also mitigating risks through strategic planning and maintaining financial flexibility, but we cannot predict the outcome of our mitigation strategies or the ultimate impact of tariffs and the global macroeconomic environment on our financial condition or results of operations.
Business Acquisitions
On August 8, 2024, we completed the acquisition of substantially all of the assets of Secure Path Networks, LLC doing business as Resourcive ("Resourcive"), a leading technology advisor. Resourcive delivers strategic IT sourcing solutions to mid-market and enterprise businesses.
On August 15, 2024, we completed the acquisition of substantially all of the assets of Advantix Solutions Group, Inc. ("Advantix"), a managed connectivity experience provider specializing in wireless enablement solutions.
Restructuring
In September 2024, as part of a strategic review of organizational structure and operations, the Company executed a cost reduction and restructuring program to align our cost structure with demand expectations in our hardware business. These actions are expected to result in approximately $10.5 million in annualized savings in selling, general and administrative expenses.
Our Strategy
Our strategy is to drive sustainable, profitable growth by orchestrating hybrid technology solutions through a growing ecosystem of partners by leveraging our people, processes and tools. Our goal is to provide exceptional experiences for our customers, suppliers and employees through operational excellence. Our hybrid distribution strategy utilizes multiple sales models to offer hardware, SaaS, and connectivity and cloud services from leading technology suppliers to customers that solve end-users’ challenges. ScanSource enables customers to deliver solutions for their end-users to address changing buying and consumption patterns. Our solutions may include a combination of offerings from multiple suppliers or give our customers access to additional services. As a trusted adviser to our customers, we provide solutions through our strong understanding of end-user needs.
28

Table of Contents
Results of Operations
Net Sales
We have two reportable segments, which are based on sales channels. The following tables summarize our net sales results by operating segment and by geographic location for the quarters and nine months ended March 31, 2025 and 2024:

| Quarter ended March 31, |  |  |  | % Change, Constant Currency, Excluding Divestitures and Acquisitions (a)
Net Sales by Segment: | 2025 |  | 2024 |  | $ Change |  | % Change |
| (in thousands) |  |  |  |
Specialty Technology Solutions | $ | 678,433 |  |  | $ | 729,834 |  |  | $ | (51,401) |  |  | (7.0) | % |  | (6.8) | %
Intelisys & Advisory | 26,414 |  |  | 22,765 |  |  | 3,649 |  |  | 16.0 | % |  | 4.3 | %
Total net sales | $ | 704,847 |  |  | $ | 752,599 |  |  | $ | (47,752) |  |  | (6.3) | % |  | (6.4) | %
| Nine months ended March 31, |  |  |  | % Change, Constant Currency, Excluding Divestitures and Acquisitions (a)
| 2025 |  | 2024 |  | $ Change |  | % Change |
| (in thousands) |  |  |  |
Specialty Technology Solutions | $ | 2,154,009 |  |  | $ | 2,445,298 |  |  | $ | (291,289) |  |  | (11.9) | % |  | (11.3) | %
Intelisys & Advisory | 73,915 |  |  | 68,398 |  |  | 5,517 |  |  | 8.1 | % |  | 0.9 | %
Total net sales | $ | 2,227,924 |  |  | $ | 2,513,696 |  |  | $ | (285,772) |  |  | (11.4) | % |  | (11.0) | %

(a) A reconciliation of non-GAAP net sales in constant currency, excluding divestitures and acquisitions, is presented at the end of Results of Operations, under Non-GAAP Financial Information.
Specialty Technology Solutions
The Specialty Technology Solutions segment consists of sales to channel partners in the United States, Canada and Brazil. For the quarter and nine months ended March 31, 2025, net sales decreased $51.4 million, or 7.0%, and $291.3 million, or 11.9%, respectively, compared to the prior-year periods. Excluding the impact from foreign exchange rate fluctuations and the impact of divestitures and acquisitions, adjusted net sales decreased $49.4 million, or 6.8%, and $276.3 million, or 11.3%, respectively, compared to the prior-year periods. For the quarter ended March 31, 2025, net sales decreased primarily due to lower net sales in Brazil. In North America, most of the technologies in this segment had year-over-year growth. For the nine months ended March 31, 2025, net sales decreased primarily due to soft demand in a more cautious technology spending environment.
Intelisys & Advisory
The Intelisys & Advisory segment consists of sales and services to both channel partners (Intelisys) and end-users (Advisory) in the United States. For the quarter ended March 31, 2025, net sales increased $3.6 million, or 16.0%, compared to the prior-year period. Excluding the impact from foreign exchange rate fluctuations and the impact of acquisitions, adjusted net sales increased $1.0 million, or 4.3% for the quarter ended March 31, 2025.
For the nine months ended March 31, 2025, net sales increased $5.5 million, or 8.1%, compared to the prior-year period. Excluding the impact from foreign exchange rate fluctuations and the impact of acquisitions, adjusted net sales increased $0.6 million, or 0.9% for the nine months ended March 31, 2025.
The increase in net sales for the quarter and nine months ended March 31, 2025 reflects the addition of an acquisition and Intelisys net sales growth. Quarterly net billings for Intelisys increased 6.8% over the prior-year quarter to bring annualized net billings to approximately $2.86 billion.
29

Table of Contents

| Quarter ended March 31, |  |  |  | % Change, Constant Currency, Excluding Divestitures and Acquisitions (a)
Net Sales by Geography: | 2025 |  | 2024 |  | $ Change |  | % Change |
| (in thousands) |  |  |  |
United States and Canada | $ | 656,964 |  |  | $ | 671,246 |  |  | $ | (14,282) |  |  | (2.1) | % |  | (3.5) | %
Brazil (b) | 47,883 |  |  | 81,353 |  |  | (33,470) |  |  | (41.1) | % |  | (30.4) | %
Total net sales | $ | 704,847 |  |  | $ | 752,599 |  |  | $ | (47,752) |  |  | (6.3) | % |  | (6.4) | %
| Nine months ended March 31, |  |  |  | % Change, Constant Currency, Excluding Divestitures and Acquisitions (a)
| 2025 |  | 2024 |  | $ Change |  | % Change |
| (in thousands) |  |  |  |
United States and Canada | $ | 2,056,094 |  |  | $ | 2,257,629 |  |  | $ | (201,535) |  |  | (8.9) | % |  | (9.9) | %
Brazil (b) | 171,830 |  |  | 256,067 |  |  | (84,237) |  |  | (32.9) | % |  | (20.7) | %
Total net sales | $ | 2,227,924 |  |  | $ | 2,513,696 |  |  | $ | (285,772) |  |  | (11.4) | % |  | (11.0) | %

(a) A reconciliation of non-GAAP net sales in constant currency is presented at the end of Results of Operations in the non-GAAP section.
(b) Countries outside of Brazil represent $0.1 million, or 0.2% of sales, and $0.3 million, or 0.2% of sales, for the quarter and nine months ended March 31, 2025, respectively. Countries outside of Brazil represent $0.1 million, or 0.2% of sales, and $4.3 million, or 1.7% of sales, for the quarter and nine months ended March 31, 2024, respectively.
30

Table of Contents
Gross Profit
The following table summarizes our gross profit for the quarters and nine months ended March 31, 2025 and 2024:

| Quarter ended March 31, |  |  |  |  |  | % of Net Sales March 31,
| 2025 |  | 2024 |  | $ Change |  | % Change |  | 2025 |  | 2024
| (in thousands) |  |  |  |  |  |
Specialty Technology Solutions | $ | 73,994 |  |  | $ | 71,840 |  |  | $ | 2,154 |  |  | 3.0 | % |  | 10.9 | % |  | 9.8 | %
Intelisys & Advisory | 26,208 |  |  | 22,641 |  |  | 3,567 |  |  | 15.8 | % |  | 99.2 | % |  | 99.5 | %
Gross profit | $ | 100,202 |  |  | $ | 94,481 |  |  | $ | 5,721 |  |  | 6.1 | % |  | 14.2 | % |  | 12.6 | %
| Nine months ended March 31, |  |  |  |  |  | % of Net Sales March 31,
| 2025 |  | 2024 |  | $ Change |  | % Change |  | 2025 |  | 2024
| (in thousands) |  |  |  |  |  |
Specialty Technology Solutions | $ | 230,215 |  |  | $ | 233,695 |  |  | $ | (3,480) |  |  | (1.5) | % |  | 10.7 | % |  | 9.6 | %
Intelisys & Advisory | 73,329 |  |  | 68,043 |  |  | 5,286 |  |  | 7.8 | % |  | 99.2 | % |  | 99.5 | %
Gross profit | $ | 303,544 |  |  | $ | 301,738 |  |  | $ | 1,806 |  |  | 0.6 | % |  | 13.6 | % |  | 12.0 | %

Our gross profit is primarily affected by sales volume and gross margin mix. Gross margin mix is impacted by multiple factors, which include sales mix (proportion of sales of higher margin products or services relative to total sales), vendor program recognition (consisting of volume rebates, inventory price changes and purchase discounts) and freight costs. Increases in vendor program recognition decrease cost of goods sold, thereby increasing gross profit. Net sales derived from our Intelisys business contribute 100% to our gross profit dollars and margin as they have no associated cost of goods sold.
Specialty Technology Solutions
For the quarter ended March 31, 2025, gross profit dollars for the Specialty Technology Solutions segment increased $2.2 million, or 3.0%, compared to the prior-year quarter. Vendor program recognition positively impacted gross profit by $7.2 million, offsetting the impact of lower sales volumes of $5.0 million. Gross profit margin increased 106 basis points over the prior-year quarter to 10.9%.
For the nine months ended March 31, 2025, gross profit dollars decreased $3.5 million, or 1.5%, compared to the prior-year period. Lower sales volume reduced gross profit dollars by $27.8 million. Gross margin mix positively impacted gross profit by $24.3 million largely due to higher vendor program recognition and a more favorable sales mix. Gross profit margin increased 113 basis points year-over-year to 10.7%.
Intelisys & Advisory
For the quarter ended March 31, 2025, gross profit dollars for the Intelisys & Advisory segment increased $3.6 million, or 15.8%, compared to the prior-year quarter. Higher sales volume, largely due to the impact of our Resourcive acquisition, increased gross profit for the quarter. Gross profit margin decreased 24 basis points compared to the prior-year quarter to 99.2%, reflecting the addition of professional services to the sales mix.
For the nine months ended March 31, 2025, gross profit dollars increased $5.3 million, or 7.8%, compared to the prior-year period. Higher sales volume, largely due to the acquisition of Resourcive, increased gross profit for the nine-month period. Gross profit margin decreased 27 basis points compared to the prior-year nine-month period to 99.2%, reflecting the addition of professional services to the sales mix.
Operating Expenses
The following table summarizes our operating expenses for the quarters and nine months ended March 31, 2025 and 2024:
31

Table of Contents

| Quarter ended March 31, |  |  |  |  |  | % of Net Sales March 31,
| 2025 |  | 2024 |  | $ Change |  | % Change |  | 2025 |  | 2024
| (in thousands) |  |  |  |  |  |
Selling, general and administrative expenses | $ | 69,698 |  |  | $ | 66,574 |  |  | $ | 3,124 |  |  | 4.7 | % |  | 9.9 | % |  | 8.8 | %
Depreciation expense | 2,320 |  |  | 2,690 |  |  | (370) |  |  | (13.8) | % |  | 0.3 | % |  | 0.4 | %
Intangible amortization expense | 4,941 |  |  | 3,752 |  |  | 1,189 |  |  | 31.7 | % |  | 0.7 | % |  | 0.5 | %
Restructuring and other charges | — |  |  | 3,923 |  |  | (3,923) |  |  | (100.0) | % |  | 0.0 | % |  | 0.5 | %
Change in fair value of contingent consideration | 904 |  |  | — |  |  | 904 |  |  | *nm |  | 0.1 | % |  | 0.0 | %
Operating expenses | $ | 77,863 |  |  | $ | 76,939 |  |  | $ | 924 |  |  | 1.2 | % |  | 11.0 | % |  | 10.2 | %
| Nine months ended March 31, |  |  |  |  |  | % of Net Sales March 31,
| 2025 |  | 2024 |  | $ Change |  | % Change |  | 2025 |  | 2024
| (in thousands) |  |  |  |  |  |
Selling, general and administrative expenses | $ | 215,324 |  |  | $ | 208,930 |  |  | $ | 6,394 |  |  | 3.1 | % |  | 9.7 | % |  | 8.3 | %
Depreciation expense | 8,079 |  |  | 8,449 |  |  | (370) |  |  | (4.4) | % |  | 0.4 | % |  | 0.3 | %
Intangible amortization expense | 14,300 |  |  | 11,982 |  |  | 2,318 |  |  | 19.3 | % |  | 0.6 | % |  | 0.5 | %
Restructuring and other charges | 5,381 |  |  | 3,923 |  |  | 1,458 |  |  | 37.2 | % |  | 0.2 | % |  | 0.2 | %
Change in fair value of contingent consideration | 2,047 |  |  | — |  |  | 2,047 |  |  | *nm |  | 0.1 | % |  | 0.0 | %
Operating expenses | $ | 245,131 |  |  | $ | 233,284 |  |  | $ | 11,847 |  |  | 5.1 | % |  | 11.0 | % |  | 9.3 | %

Selling, general and administrative expenses (“SG&A”) increased by $3.1 million, or 4.7%, and $6.4 million, or 3.1% for the quarter and nine months ended March 31, 2025, respectively compared to the prior-year periods. The increase for the quarter is primarily attributable to increased costs related to acquisitions. The increase for the nine-month period is primarily attributable to increased costs related to acquisitions as well as increased customer specific bad debt expense.
The increase in amortization expense of $1.2 million and $2.3 million during the quarter and nine months ended March 31, 2025, respectively, is largely due to intangible assets acquired in our acquisitions of Advantix and Resourcive.
Restructuring and other charges of $5.4 million were incurred during the nine months ended March 31, 2025 compared to charges of $3.9 million for the quarter and nine months ended March 31, 2024. Restructuring and other charges relate to employee separation and benefit costs in connection with our expense reduction and restructuring plans implemented during the current and prior fiscal year.
We present changes in fair value of the contingent consideration owed to the former shareholders of businesses that we acquire as a separate line item in operating expenses. We recorded a fair value adjustment expense of $0.9 million and $2.0 million in the quarter and nine months ended March 31, 2025, respectively. The expense from changes in fair value of contingent consideration for the quarter and nine months is largely due to the recurring amortization of the unrecognized fair value discount.
32

Table of Contents
Operating Income
The following table summarizes our operating income for the quarters and nine months ended March 31, 2025 and 2024:

| Quarter ended March 31, |  |  |  |  |  | % of Net Sales March 31,
| 2025 |  | 2024 |  | $ Change |  | % Change |  | 2025 |  | 2024
| (in thousands) |  |  |  |  |  |
Specialty Technology Solutions | $ | 14,294 |  |  | $ | 14,580 |  |  | $ | (286) |  |  | (2.0) | % |  | 2.1 | % |  | 2.0 | %
Intelisys & Advisory | 8,320 |  |  | 7,489 |  |  | 831 |  |  | 11.1 | % |  | 31.5 | % |  | 32.9 | %
Corporate | (275) |  |  | (4,527) |  |  | 4,252 |  |  | nm* |  | nm* |  | nm*
Operating income | $ | 22,339 |  |  | $ | 17,542 |  |  | $ | 4,797 |  |  | 27.3 | % |  | 3.2 | % |  | 2.3 | %
| Nine months ended March 31, |  |  |  |  |  | % of Net Sales March 31,
| 2025 |  | 2024 |  | $ Change |  | % Change |  | 2025 |  | 2024
| (in thousands) |  |  |  |  |  |
Specialty Technology Solutions | $ | 45,110 |  |  | $ | 51,914 |  |  | $ | (6,804) |  |  | (13.1) | % |  | 2.1 | % |  | 2.1 | %
Intelisys & Advisory | 21,173 |  |  | 22,411 |  |  | (1,238) |  |  | (5.5) | % |  | 28.6 | % |  | 32.8 | %
Corporate | (7,870) |  |  | (5,871) |  |  | (1,999) |  |  | nm* |  | nm* |  | nm*
Operating income | $ | 58,413 |  |  | $ | 68,454 |  |  | $ | (10,041) |  |  | (14.7) | % |  | 2.6 | % |  | 2.7 | %

*nm - percentages are not meaningful
Specialty Technology Solutions
For the Specialty Technology Solutions segment, operating income decreased $0.3 million, or 2.0%, and $6.8 million, or 13.1% for the quarter and nine months ended March 31, 2025, respectively, compared to the prior-year periods. Operating margin was 2.1% for the quarter and nine months ended March 31, 2025. The decrease in operating income for the quarter is primarily due to higher amortization expense related to a recent acquisition. The decrease in operating income for the nine months is primarily due to lower gross profits from lower sales volumes as well as higher bad debt expense.
Intelisys & Advisory
For the Intelisys & Advisory segment, operating income increased $0.8 million, or 11.1%, for the quarter ended March 31, 2025. Operating margin decreased to 31.5% for the quarter ended March 31, 2025. The increase in operating income for the quarter ended March 31, 2025 is a result of higher gross profits for the quarter.
For the nine months ended March 31, 2025, operating income decreased $1.2 million, or 5.5%, compared to the prior-year period. Operating margin decreased to 28.6% for the nine months ended March 31, 2025. The decrease in operating income for the nine-month period ended March 31, 2025 is primarily driven by expense related to the change in fair value of contingent consideration.
Corporate
For the quarter and nine months ended March 31, 2025, Corporate operating losses of $0.3 million and $7.9 million, respectively, represent restructuring and acquisition-related costs and a legal settlement incurred during the fiscal year.
Total Other (Income) Expense
The following table summarizes our total other (income) expense for the quarters and nine months ended March 31, 2025 and 2024:
33

Table of Contents

| Quarter ended March 31, |  |  |  |  |  | % of Net Sales March 31,
| 2025 |  | 2024 |  | $ Change |  | % Change |  | 2025 |  | 2024
| (in thousands) |  |  |  |  |  |
Interest expense | $ | 1,836 |  |  | $ | 2,001 |  |  | $ | (165) |  |  | (8.2) | % |  | 0.3 | % |  | 0.3 | %
Interest income | (2,841) |  |  | (2,652) |  |  | (189) |  |  | 7.1 | % |  | (0.4) | % |  | (0.4) | %
Net foreign exchange losses | 130 |  |  | 508 |  |  | (378) |  |  | (74.4) | % |  | 0.0 | % |  | 0.1 | %
Other, net | (1,012) |  |  | (267) |  |  | (745) |  |  | 279.0 | % |  | (0.1) | % |  | (0.0) | %
Total other (income) expense, net | $ | (1,887) |  |  | $ | (410) |  |  | $ | (1,477) |  |  | 360.2 | % |  | (0.3) | % |  | (0.1) | %
| Nine months ended March 31, |  |  |  |  |  | % of Net Sales March 31,
| 2025 |  | 2024 |  | $ Change |  | % Change |  | 2025 |  | 2024
| (in thousands) |  |  |  |  |  |
Interest expense | $ | 5,914 |  |  | $ | 10,947 |  |  | $ | (5,033) |  |  | (46.0) | % |  | 0.3 | % |  | 0.4 | %
Interest income | (8,193) |  |  | (6,096) |  |  | (2,097) |  |  | 34.4 | % |  | (0.4) | % |  | (0.2) | %
Net foreign exchange losses | 212 |  |  | 1,632 |  |  | (1,420) |  |  | (87.0) | % |  | 0.0 | % |  | 0.1 | %
Gain on sale of business | — |  |  | (14,533) |  |  | 14,533 |  |  | nm* |  | — | % |  | (0.6) | %
Other, net | (6,418) |  |  | (641) |  |  | (5,777) |  |  | nm* |  | (0.3) | % |  | (0.0) | %
Total other (income) expense, net | $ | (8,485) |  |  | $ | (8,691) |  |  | $ | 206 |  |  | (2.4) | % |  | (0.4) | % |  | (0.3) | %

*nm - percentages are not meaningful
Interest expense consists primarily of interest incurred on borrowings, non-utilization fees charged on the revolving credit facility and amortization of debt issuance costs. Interest expense decreased for the quarter and nine months ended March 31, 2025 compared to the prior-year periods, primarily from lower average borrowings on our multi-currency revolving credit facility.
Interest income increased for the quarter and nine months ended March 31, 2025 primarily from interest earned on higher average cash balances in the United States.
Net foreign exchange gains and losses consist of foreign currency transactional and functional currency re-measurements, offset by net foreign exchange forward contracts gains and losses. Foreign exchange gains and losses are generated as the result of fluctuations in the value of the U.S. dollar versus the Brazilian real, the Canadian dollar versus the U.S. dollar, the euro versus the U.S. dollar, and the British pound versus the U.S. dollar. We partially offset foreign currency exposure with the use of foreign exchange contracts to hedge against these exposures. The costs associated with foreign exchange forward contracts are included in the net foreign exchange losses.
For the quarter and nine months ended March 31, 2025, we recognized a gain of $1.0 million and $6.4 million, respectively, primarily as a result of an insurance recovery in connection with the cybersecurity attack in the fourth quarter of fiscal year 2023.
Provision for Income Taxes
For the quarter and nine months ended March 31, 2025, income tax expense was $6.8 million and $15.4 million, respectively, reflecting an effective tax rate of 28.0% and 23.1%. In comparison, for the quarter and nine months ended March 31, 2024, income tax expense was $5.1 million and $16.2 million reflecting an effective tax rate of 28.7% and 21.0%, respectively. The decrease in the effective tax rate for the quarter is primarily driven by a change in the geographical mix of earnings. The increase in the effective tax rate for the nine-month period is primarily due to the higher amount of discrete tax benefits recognized in the prior-year period. We expect the effective tax rate, excluding discrete items, for fiscal year 2025 to be approximately 28.2% to 29.2%. See Note 13 - Income Taxes to the Notes to Consolidated Financial Statements for further discussion.
34

Table of Contents
Non-GAAP Financial Information
Evaluating Financial Condition and Operating Performance
In addition to disclosing results that are determined in accordance with United States generally accepted accounting principles (“US GAAP” or “GAAP”), we also disclose certain non-GAAP financial measures. These measures include non-GAAP operating income; non-GAAP pre-tax income; non-GAAP net income; non-GAAP EPS; adjusted earnings before interest expense, income taxes, depreciation, and amortization (“adjusted EBITDA”); adjusted return on invested capital (“adjusted ROIC”); and constant currency. Constant currency is a measure that excludes the translation exchange impact from changes in foreign currency exchange rates between reporting periods. We use non-GAAP financial measures to better understand and evaluate performance, including comparisons from period to period.
These non-GAAP financial measures have limitations as analytical tools, and the non-GAAP financial measures that we report may not be comparable to similarly titled amounts reported by other companies. Analysis of results and outlook on a non-GAAP basis should be considered in addition to, and not in substitution for or as superior to, measurements of financial performance prepared in accordance with US GAAP.
Adjusted Return on Invested Capital
Adjusted ROIC assists us in comparing our performance over various reporting periods on a consistent basis because it removes from our operating results the impact of items that do not reflect our core operating performance. We believe the calculation of adjusted ROIC provides useful information to investors and is an additional relevant comparison of our performance during the year.
Adjusted EBITDA starts with net income and adds back interest expense, income tax expense, depreciation expense, amortization of intangible assets, share-based compensation expense, and other non-GAAP adjustments. Since adjusted EBITDA excludes some non-cash costs of investing in our business and people, we believe that adjusted EBITDA shows the profitability from our business operations more clearly.
We calculate adjusted ROIC as adjusted EBITDA, divided by invested capital. Invested capital is defined as average equity plus average daily funded interest-bearing debt for the period. The following table summarizes annualized adjusted ROIC for the quarters ended March 31, 2025 and 2024, respectively:

| Quarter ended March 31, |  |
| 2025 |  | 2024 |  |  |  |
Adjusted return on invested capital ratio, annualized (a) | 13.6 | % |  | 12.1 | % |  |  |  |

(a)The annualized EBITDA amount is divided by days in the quarter times 365 days per year, or 366 days for leap year. There were 90 days in the current and 91 days in the prior-year quarter.
The components of this calculation and reconciliation to our financial statements are shown on the following schedule:
35

Table of Contents

| Quarter ended March 31, |  |
| 2025 |  | 2024 |  |  |  |
| (in thousands) |  |
Reconciliation of net income to adjusted EBITDA: |  |  |
Net income (GAAP) | $ | 17,431 |  |  | $ | 12,806 |  |  |  |  |
Plus: Interest expense | 1,836 |  |  | 2,001 |  |  |  |  |
Plus: Income taxes | 6,795 |  |  | 5,146 |  |  |  |  |
Plus: Depreciation and amortization | 7,492 |  |  | 6,742 |  |  |  |  |
EBITDA (non-GAAP) | 33,554 |  |  | 26,695 |  |  |  |  |
Plus: Change in fair value of contingent consideration | 904 |  |  | — |  |  |  |  |
Plus: Share-based compensation | 2,896 |  |  | 2,388 |  |  |  |  |
Plus: Acquisition and divestiture costs (a) | 204 |  |  | 511 |  |  |  |  |
Plus: Cyberattack restoration costs | 71 |  |  | 93 |  |  |  |  |
Plus: Restructuring costs | — |  |  | 3,923 |  |  |  |  |
Plus: Tax recovery | (1,820) |  |  | (515) |  |  |  |  |
Plus: Insurance recovery, net of payments | (756) |  |  | — |  |  |  |  |
Adjusted EBITDA (numerator for adjusted ROIC) (non-GAAP) | $ | 35,053 |  |  | $ | 33,095 |  |  |  |  |

| Quarter ended March 31, |  |
| 2025 |  | 2024 |  |  |  |
| (in thousands) |  |
Invested capital calculations: |  |  |
Equity – beginning of the quarter | $ | 900,662 |  |  | $ | 953,601 |  |  |  |  |
Equity – end of the quarter | 901,746 |  |  | 944,051 |  |  |  |  |
Plus: Change in fair value of contingent consideration, net of tax | 681 |  |  | — |  |  |  |  |
Plus: Share-based compensation, net | 2,176 |  |  | 1,784 |  |  |  |  |
Plus: Acquisition and divestiture costs (a) | 204 |  |  | 511 |  |  |  |  |
Plus: Cyberattack restoration costs, net | 54 |  |  | 69 |  |  |  |  |
Plus: Restructuring, net | — |  |  | 2,935 |  |  |  |  |
Plus: Insurance recovery, net of payments | (570) |  |  | — |  |  |  |  |
Plus: Tax recovery, net | (1,201) |  |  | (1,648) |  |  |  |  |
Average equity | 901,876 |  |  | 950,652 |  |  |  |  |
Average funded debt (b) | 140,207 |  |  | 153,131 |  |  |  |  |
Invested capital (denominator for adjusted ROIC) (non-GAAP) | $ | 1,042,083 |  |  | $ | 1,103,783 |  |  |  |  |

(a) Acquisition and divestiture costs are generally non-deductible for tax purposes.
(b)Average funded debt is calculated as the daily average amounts outstanding on our short-term and long-term interest-bearing debt.
Net Sales in Constant Currency Excluding Acquisitions and Divestitures
We make references to “constant currency,” a non-GAAP performance measure that excludes the foreign exchange rate impact from fluctuations in the average foreign exchange rates between reporting periods. Constant currency is calculated by translating current period results from currencies other than the U.S. dollar into U.S. dollars using the comparable average foreign exchange rates from the prior-year period. We also exclude the impact of acquisitions or divestitures prior to the first full year of operations from the acquisition or divestiture date in order to show net sales results on an organic basis. This information is provided to analyze underlying trends without the translation impact of fluctuations in foreign currency rates and the impact of acquisitions and divestitures. Below we show organic growth by providing a non-GAAP reconciliation of net sales in constant currency excluding acquisitions and divestitures:
36

Table of Contents

Net Sales by Segment: |  |  |  |  |
| Quarter ended March 31, |  |  |  |
| 2025 |  | 2024 |  | $ Change |  | % Change
Specialty Technology Solutions: | (in thousands) |  |  |  |
Net sales, reported | $ | 678,433 |  |  | $ | 729,834 |  |  | $ | (51,401) |  |  | (7.0) | %
Foreign exchange impact (a) | 8,702 |  |  | — |  |  |  |  |
Less: Acquisitions | (6,660) |  |  | — |  |  |  |  |
Non-GAAP net sales | $ | 680,475 |  |  | $ | 729,834 |  |  | $ | (49,359) |  |  | (6.8) | %
Intelisys & Advisory: |  |  |  |  |  |  |
Net sales, reported | $ | 26,414 |  |  | $ | 22,765 |  |  | $ | 3,649 |  |  | 16.0 | %
Foreign exchange impact (a) | 3 |  |  | — |  |  |  |  |
Less: Acquisitions | (2,662) |  |  | — |  |  |  |  |
Non-GAAP net sales | $ | 23,755 |  |  | $ | 22,765 |  |  | $ | 990 |  |  | 4.3 | %
Consolidated: |  |  |  |  |  |  |
Net sales, reported | $ | 704,847 |  |  | $ | 752,599 |  |  | $ | (47,752) |  |  | (6.3) | %
Foreign exchange impact (a) | 8,705 |  |  | — |  |  |  |  |
Less: Acquisitions | (9,322) |  |  | — |  |  |  |  |
Non-GAAP net sales | $ | 704,230 |  |  | $ | 752,599 |  |  | $ | (48,369) |  |  | (6.4) | %
(a) Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended March 31, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended March 31, 2024.

37

Table of Contents

Net Sales by Segment: |  |  |  |  |
| Nine months ended March 31, |  |  |  |
| 2025 |  | 2024 |  | $ Change |  | % Change
Specialty Technology Solutions | (in thousands) |  |  |  |
Net sales, reported | $ | 2,154,009 |  |  | $ | 2,445,298 |  |  | $ | (291,289) |  |  | (11.9) | %
Foreign exchange impact (a) | 28,070 |  |  | — |  |  |  |  |
Less: Divestitures | — |  |  | (4,019) |  |  |  |  |
Less: Acquisitions | (17,059) |  |  | — |  |  |  |  |
Non-GAAP net sales | $ | 2,165,020 |  |  | $ | 2,441,279 |  |  | $ | (276,259) |  |  | (11.3) | %
Intelisys & Advisory |  |  |  |  |  |  |
Net sales, reported | $ | 73,915 |  |  | $ | 68,398 |  |  | $ | 5,517 |  |  | 8.1 | %
Foreign exchange impact (a) | (5) |  |  | — |  |  |  |  |
Less: Acquisitions | (4,924) |  |  | — |  |  |  |  |
Non-GAAP net sales | $ | 68,986 |  |  | $ | 68,398 |  |  | $ | 588 |  |  | 0.9 | %
Consolidated: |  |  |  |  |  |  |
Net sales, reported | $ | 2,227,924 |  |  | $ | 2,513,696 |  |  | $ | (285,772) |  |  | (11.4) | %
Foreign exchange impact (a) | 28,065 |  |  | — |  |  |  |  |
Less: Divestitures | — |  |  | (4,019) |  |  |  |  |
Less: Acquisitions | (21,983) |  |  | — |  |  |  |  |
Non-GAAP net sales | $ | 2,234,006 |  |  | $ | 2,509,677 |  |  | $ | (275,671) |  |  | (11.0) | %
(a) Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the nine months ended March 31, 2025 into U.S. dollars using the average foreign exchange rates for the nine months ended March 31, 2024.

38

Table of Contents

Net Sales by Geography: |  |  |  |  |
| Quarter ended March 31, |  |  |  |
| 2025 |  | 2024 |  | $ Change |  | % Change
United States and Canada: | (in thousands) |  |  |  |
Net sales, as reported | $ | 656,964 |  |  | $ | 671,246 |  |  | $ | (14,282) |  |  | (2.1) | %
Less: Acquisitions | (9,322) |  |  | — |  |  |  |  |
Non-GAAP net sales | $ | 647,642 |  |  | $ | 671,246 |  |  | $ | (23,604) |  |  | (3.5) | %
Brazil: |  |  |  |  |  |  |
Net sales, reported (a) | $ | 47,883 |  |  | $ | 81,353 |  |  | $ | (33,470) |  |  | (41.1) | %
Foreign exchange impact (b) | 8,705 |  |  | — |  |  |  |  |
Non-GAAP net sales, constant currency | $ | 56,588 |  |  | $ | 81,353 |  |  | $ | (24,765) |  |  | (30.4) | %
Consolidated: |  |  |  |  |  |  |
Net sales, reported (a) | $ | 704,847 |  |  | $ | 752,599 |  |  | $ | (47,752) |  |  | (6.3) | %
Foreign exchange impact (b) | 8,705 |  |  | — |  |  |  |  |
Less: Acquisitions | (9,322) |  |  | — |  |  |  |  |
Non-GAAP net sales, constant currency | $ | 704,230 |  |  | $ | 752,599 |  |  | $ | (48,369) |  |  | (6.4) | %
(a) Countries outside of Brazil represent $0.1 million, or 0.2% of sales, for the quarter ended March 31, 2025 and $0.1 million, or 0.2% of sales, for the quarter ended March 31, 2024.
(b) Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended March 31, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended March 31, 2024.
| Nine months ended March 31, |  |  |  |
| 2025 |  | 2024 |  | $ Change |  | % Change
United States and Canada: | (in thousands) |  |  |  |
Net sales, as reported | $ | 2,056,094 |  |  | $ | 2,257,629 |  |  | $ | (201,535) |  |  | (8.9) | %
Less: Acquisitions | (21,983) |  |  | — |  |  |  |  |
Non-GAAP net sales | 2,034,111 |  |  | 2,257,629 |  |  | $ | (223,518) |  |  | (9.9) | %
Brazil: |  |  |  |  |  |  |
Net sales, reported (a) | $ | 171,830 |  |  | $ | 256,067 |  |  | $ | (84,237) |  |  | (32.9) | %
Foreign exchange impact (b) | 28,065 |  |  | — |  |  |  |  |
Less: Divestitures | — |  |  | (4,019) |  |  |  |  |
Non-GAAP net sales, constant currency | $ | 199,895 |  |  | $ | 252,048 |  |  | $ | (52,153) |  |  | (20.7) | %
Consolidated: |  |  |  |  |  |  |
Net sales, reported | $ | 2,227,924 |  |  | $ | 2,513,696 |  |  | $ | (285,772) |  |  | (11.4) | %
Foreign exchange impact (b) | 28,065 |  |  | — |  |  |  |  |
Less: Divestitures | — |  |  | (4,019) |  |  |  |  |
Less: Acquisitions | (21,983) |  |  | — |  |  |  |  |
Non-GAAP net sales, constant currency | $ | 2,234,006 |  |  | $ | 2,509,677 |  |  | $ | (275,671) |  |  | (11.0) | %
(a) Countries outside of Brazil represent $0.3 million, or 0.2% of sales, for the nine months ended March 31, 2025 and $4.3 million, or 1.7% of sales, for the nine months ended March 31, 2024.
(b) Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the nine months ended March 31, 2025 into U.S. dollars using the average foreign exchange rates for the nine months ended March 31, 2024.

39

Table of Contents

Operating Income by Segment: |  |  |  |  |  |  |  |  |
| Quarter ended March 31, |  |  |  |  |  | % of Net Sales March 31,
| 2025 |  | 2024 |  | $ Change |  | % Change |  | 2025 |  | 2024
Specialty Technology Solutions: | (in thousands) |  |  |  |  |  |  |  |
GAAP operating income | $ | 14,294 |  |  | $ | 14,580 |  |  | $ | (286) |  |  | (2.0) | % |  | 2.1 | % |  | 2.0 | %
Adjustments: |  |  |  |  |  |  |  |  |  |  |
Amortization of intangible assets | 2,753 |  |  | 1,828 |  |  | 925 |  |  |  |  |  |  |
Change in fair value of contingent consideration | 94 |  |  | — |  |  | 94 |  |  |  |  |  |  |
Tax recovery, net | (1,820) |  |  | (515) |  |  | (1,305) |  |  |  |  |  |  |
Non-GAAP operating income | $ | 15,321 |  |  | $ | 15,893 |  |  | $ | (572) |  |  | (3.6) | % |  | 2.3 | % |  | 2.2 | %
Intelisys & Advisory: |  |  |  |  |  |  |  |  |  |  |
GAAP operating income | $ | 8,320 |  |  | $ | 7,489 |  |  | $ | 831 |  |  | 11.1 | % |  | 31.5 | % |  | 32.9 | %
Adjustments: |  |  |  |  |  |  |  |  |  |  |
Amortization of intangible assets | 2,188 |  |  | 1,924 |  |  | 264 |  |  |  |  |  |  |
Change in fair value of contingent consideration | 810 |  |  | — |  |  | 810 |  |  |  |  |  |  |
Non-GAAP operating income | $ | 11,318 |  |  | $ | 9,413 |  |  | $ | 1,905 |  |  | 20.2 | % |  | 42.8 | % |  | 41.3 | %
Corporate: |  |  |  |  |  |  |  |  |  |  |
GAAP operating loss | $ | (275) |  |  | $ | (4,527) |  |  | $ | 4,252 |  |  | nm* |  | nm* |  | nm*
Adjustments: |  |  |  |  |  |  |  |  |  |  |
Acquisition and divestiture costs | 204 |  |  | 511 |  |  | (307) |  |  |  |  |  |  |
Restructuring costs | — |  |  | 3,923 |  |  | (3,923) |  |  |  |  |  |  |
Cyberattack restoration costs | 71 |  |  | 93 |  |  | (22) |  |  |  |  |  |  |
Non-GAAP operating income | $ | — |  |  | $ | — |  |  | $ | — |  |  | nm* |  | nm* |  | nm*
Consolidated: |  |  |  |  |  |  |  |  |  |  |
GAAP operating income | $ | 22,339 |  |  | $ | 17,542 |  |  | $ | 4,797 |  |  | 27.3 | % |  | 3.2 | % |  | 2.3 | %
Adjustments: |  |  |  |  |  |  |  |  |  |  |
Amortization of intangible assets | 4,941 |  |  | 3,752 |  |  | 1,189 |  |  |  |  |  |  |
Change in fair value of contingent consideration | 904 |  |  | — |  |  | 904 |  |  |  |  |  |  |
Tax recovery (a) | (1,820) |  |  | (515) |  |  | (1,305) |  |  |  |  |  |  |
Acquisition and divestiture costs | 204 |  |  | 511 |  |  | (307) |  |  |  |  |  |  |
Restructuring costs | — |  |  | 3,923 |  |  | (3,923) |  |  |  |  |  |  |
Cyberattack restoration costs | 71 |  |  | 93 |  |  | (22) |  |  |  |  |  |  |
Non-GAAP operating income | $ | 26,639 |  |  | $ | 25,306 |  |  | $ | 1,333 |  |  | 5.3 | % |  | 3.8 | % |  | 3.4 | %
(a) Recovery of prior period withholding taxes in Brazil.

40

Table of Contents

Operating Income by Segment: |  |  |  |  |  |  |  |  |
| Nine months ended March 31, |  |  |  |  |  | % of Net Sales March 31,
| 2025 |  | 2024 |  | $ Change |  | % Change |  | 2025 |  | 2024
Specialty Technology Solutions: | (in thousands) |  |  |  |  |  |  |  |
GAAP operating income | $ | 45,110 |  |  | $ | 51,914 |  |  | $ | (6,804) |  |  | (13.1) | % |  | 2.1 | % |  | 2.1 | %
Adjustments: |  |  |  |  |  |  |  |  |  |  |
Amortization of intangible assets | 7,769 |  |  | 6,224 |  |  | 1,545 |  |  |  |  |  |  |
Change in fair value of contingent consideration | 567 |  |  | — |  |  | 567 |  |  |  |  |  |  |
Tax recovery (a) | (2,570) |  |  | (1,901) |  |  | (669) |  |  |  |  |  |  |
Non-GAAP operating income | $ | 50,876 |  |  | $ | 56,237 |  |  | $ | (5,361) |  |  | (9.5) | % |  | 2.4 | % |  | 2.3 | %
Intelisys & Advisory: |  |  |  |  |  |  |  |  |  |  |
GAAP operating income | $ | 21,173 |  |  | $ | 22,411 |  |  | $ | (1,238) |  |  | (5.5) | % |  | 28.6 | % |  | 32.8 | %
Adjustments: |  |  |  |  |  |  |  |  |  |  |
Amortization of intangible assets | 6,531 |  |  | 5,758 |  |  | 773 |  |  |  |  |  |  |
Change in fair value of contingent consideration | 1,480 |  |  | — |  |  | 1,480 |  |  |  |  |  |  |
Non-GAAP operating income | $ | 29,184 |  |  | $ | 28,169 |  |  | $ | 1,015 |  |  | 3.6 | % |  | 39.5 | % |  | 41.2 | %
Corporate: |  |  |  |  |  |  |  |  |  |  |
GAAP operating loss | $ | (7,870) |  |  | $ | (5,871) |  |  | $ | (1,999) |  |  | nm* |  | nm* |  | nm*
Adjustments: |  |  |  |  |  |  |  |  |  |  |
Cyberattack restoration costs | 177 |  |  | 733 |  |  | (556) |  |  |  |  |  |  |
Acquisition and divestiture costs | 733 |  |  | 1,215 |  |  | (482) |  |  |  |  |  |  |
Restructuring costs | 5,381 |  |  | 3,923 |  |  | 1,458 |  |  |  |  |  |  |
Legal settlement | 1,579 |  |  | — |  |  | 1,579 |  |  |  |  |  |  |
Non-GAAP operating income | $ | — |  |  | $ | — |  |  | $ | — |  |  | nm* |  | nm* |  | nm*
Consolidated: |  |  |  |  |  |  |  |  |  |  |
GAAP operating income | $ | 58,413 |  |  | $ | 68,454 |  |  | $ | (10,041) |  |  | (14.7) | % |  | 2.6 | % |  | 2.7 | %
Adjustments: |  |  |  |  |  |  |  |  |  |  |
Amortization of intangible assets | 14,300 |  |  | 11,982 |  |  | 2,318 |  |  |  |  |  |  |
Change in fair value of contingent consideration | 2,047 |  |  | — |  |  | 2,047 |  |  |  |  |  |  |
Cyberattack restoration costs | 177 |  |  | 733 |  |  | (556) |  |  |  |  |  |  |
Tax recovery (a) | (2,570) |  |  | (1,901) |  |  | (669) |  |  |  |  |  |  |
Acquisition and divestiture costs | 733 |  |  | 1,215 |  |  | (482) |  |  |  |  |  |  |
Restructuring costs | 5,381 |  |  | 3,923 |  |  | 1,458 |  |  |  |  |  |  |
Legal settlement | 1,579 |  |  | — |  |  | 1,579 |  |  |  |  |  |  |
Non-GAAP operating income | $ | 80,060 |  |  | $ | 84,406 |  |  | $ | (4,346) |  |  | (5.1) | % |  | 3.6 | % |  | 3.4 | %
(a) Recovery of prior period withholding taxes in Brazil.

41

Table of Contents
Additional Non-GAAP Metrics
To evaluate current period performance on a more consistent basis with prior periods, we disclose non-GAAP SG&A expenses, non-GAAP operating income, non-GAAP pre-tax income, non-GAAP net income and non-GAAP diluted earnings per share. Non-GAAP results exclude amortization of intangible assets related to divestitures, cyberattack restoration costs and other non-GAAP adjustments. These year-over-year metrics include the translation impact of changes in foreign currency exchange rates. These metrics are useful in assessing and understanding our operating performance, especially when comparing results with previous periods or forecasting performance for future periods. Below we provide a non-GAAP reconciliation of the aforementioned metrics adjusted for the costs and charges mentioned above:

|  |  |  |  | Quarter ended March 31, 2025
|  |  |  |  | GAAP Measure |  | Intangible amortization expense |  | Change in fair value of contingent consideration |  | Acquisition and Divestiture costs (a) |  | Restructuring costs |  | Insurance recovery | Tax recovery |  | Cyberattack restoration costs |  |  |  | Non-GAAP measure
|  | (in thousands, except per share data)
SG&A expenses |  |  |  |  | $ | 69,698 |  |  | $ | — |  |  | $ | — |  |  | $ | (204) |  |  | $ | — |  |  | $ | — |  | $ | 1,820 |  |  | $ | (71) |  |  |  |  | $ | 71,243 |
Operating income |  |  |  |  | 22,339 |  |  | 4,941 |  |  | 904 |  |  | 204 |  |  | — |  |  | — |  | (1,820) |  |  | 71 |  |  |  |  | 26,639 |
Pre-tax income |  |  |  |  | 24,226 |  |  | 4,941 |  |  | 904 |  |  | 204 |  |  | — |  |  | (756) |  | (1,820) |  |  | 71 |  |  |  |  | 27,770 |
Net income |  |  |  |  | 17,431 |  |  | 3,699 |  |  | 681 |  |  | 204 |  |  | — |  |  | (570) |  | (1,201) |  |  | 54 |  |  |  |  | 20,298 |
Diluted EPS |  |  |  |  | $ | 0.74 |  |  | $ | 0.16 |  |  | $0.03 |  | $ | 0.01 |  |  | $ | — |  |  | $ | (0.02) |  | $ | (0.05) |  |  | $ | — |  |  |  |  | $ | 0.86 |
|  |  |  |  | Quarter ended March 31, 2024
|  |  |  |  | GAAP Measure |  | Intangible amortization expense |  | Change in fair value of contingent consideration |  | Acquisition and Divestiture costs (a) |  | Restructuring costs |  | Insurance recovery | Tax recovery |  | Cyberattack restoration costs |  |  |  | Non-GAAP measure
|  | (in thousands, except per share data)
SG&A expenses |  |  |  |  | $ | 66,574 |  |  | $ | — |  |  | $ | — |  |  | $ | (511) |  |  | $ | (3,923) |  |  | $ | — |  | $ | 515 |  |  | $ | (93) |  |  |  |  | $ | 62,562 |
Operating income |  |  |  |  | 17,542 |  |  | 3,752 |  |  | — |  |  | 511 |  |  | 3,923 |  |  | — |  | (515) |  |  | 93 |  |  |  |  | 25,306 |
Pre-tax income |  |  |  |  | 17,952 |  |  | 3,752 |  |  | — |  |  | 511 |  |  | 3,923 |  |  | — |  | (515) |  |  | 93 |  |  |  |  | 25,716 |
Net income |  |  |  |  | 12,806 |  |  | 2,788 |  |  | — |  |  | 511 |  |  | 2,935 |  |  | — |  | (1,648) |  |  | 69 |  |  |  |  | 17,461 |
Diluted EPS |  |  |  |  | $ | 0.50 |  |  | $ | 0.11 |  |  | $ | — |  |  | $ | 0.02 |  |  | $ | 0.12 |  |  | $ | — |  | $ | (0.06) |  |  | $ | — |  |  |  |  | $ | 0.69 |
(a) Acquisition and divestiture costs for the quarters ended March 31, 2025 and 2024 are generally nondeductible for tax purposes.

42

Table of Contents

|  |  |  |  | Nine months ended March 31, 2025
|  |  |  |  | GAAP Measure |  | Intangible amortization expense |  | Change in fair value of contingent consideration |  | Acquisition and Divestiture costs (a) |  | Restructuring costs |  | Tax recovery |  | Cyberattack restoration costs |  | Insurance recovery |  | Legal settlement |  | Non-GAAP measure
SG&A expenses |  |  |  |  | $ | 215,324 |  |  | $ | — |  |  | $ | — |  |  | $ | (733) |  |  | $ | — |  |  | $ | 2,570 |  |  | $ | (177) |  |  | $ | — |  |  | $ | (1,579) |  |  | $ | 215,405 |
Operating income |  |  |  |  | 58,413 |  |  | 14,300 |  |  | 2,047 |  |  | 733 |  |  | 5,381 |  |  | (2,570) |  |  | 177 |  |  | — |  |  | 1,579 |  |  | 80,060 |
Pre-tax income |  |  |  |  | 66,898 |  |  | 14,300 |  |  | 2,047 |  |  | 733 |  |  | 5,381 |  |  | (2,570) |  |  | 177 |  |  | (5,624) |  |  | 1,579 |  |  | 82,921 |
Net income |  |  |  |  | 51,458 |  |  | 10,709 |  |  | 1,542 |  |  | 733 |  |  | 4,054 |  |  | (3,761) |  |  | 133 |  |  | (4,237) |  |  | 1,189 |  |  | 61,820 |
Diluted EPS |  |  |  |  | $ | 2.13 |  |  | $ | 0.44 |  |  | $ | 0.06 |  |  | $ | 0.03 |  |  | $ | 0.17 |  |  | $ | (0.16) |  |  | $ | 0.01 |  |  | $ | (0.18) |  |  | $ | 0.05 |  |  | $ | 2.56 |
|  |  |  |  | Nine months ended March 31, 2024
|  |  |  |  | GAAP Measure |  | Intangible amortization expense |  | Change in fair value of contingent consideration |  | Acquisition and Divestiture costs (a) |  | Restructuring costs |  | Tax recovery |  | Cyberattack restoration costs |  | Insurance recovery |  | Gain on sale of a business (b) |  | Non-GAAP measure
SG&A expenses |  |  |  |  | $ | 208,930 |  |  | $ | — |  |  | $ | — |  |  | $ | (1,215) |  |  | $ | (3,923) |  |  | $ | 1,901 |  |  | $ | (733) |  |  | $ | — |  |  | $ | — |  |  | $ | 204,960 |
Operating income |  |  |  |  | 68,454 |  |  | 11,982 |  |  | — |  |  | 1,215 |  |  | 3,923 |  |  | (1,901) |  |  | 733 |  |  | — |  |  | — |  |  | 84,406 |
Pre-tax income |  |  |  |  | 77,145 |  |  | 11,982 |  |  | — |  |  | 1,215 |  |  | 3,923 |  |  | (1,901) |  |  | 733 |  |  | — |  |  | (14,533) |  |  | 78,564 |
Net income |  |  |  |  | 60,964 |  |  | 8,909 |  |  | — |  |  | 1,215 |  |  | 2,935 |  |  | (2,288) |  |  | 548 |  |  | — |  |  | (14,533) |  |  | 57,750 |
Diluted EPS |  |  |  |  | $ | 2.41 |  |  | $ | 0.35 |  |  | $ | — |  |  | $ | 0.05 |  |  | $ | 0.12 |  |  | $ | (0.09) |  |  | $ | 0.02 |  |  | $ | — |  |  | $ | (0.57) |  |  | $ | 2.28 |
(a) Acquisition and divestiture costs for the nine months ended March 31, 2025 and 2024 are generally nondeductible for tax purposes.
(b) Reflects gain on the sale of the UK-based intY business. This transaction resulted in a capital loss for tax purposes. The Company did not record a tax provision on the capital loss since there were no offsetting capital gains.

43

Table of Contents
Liquidity and Capital Resources
Our primary sources of liquidity are cash flows from operations and borrowings under our $350 million revolving credit facility. Our business requires significant investment in working capital, particularly accounts receivable and inventory, partially financed through our accounts payable to vendors, cash generated from operations and revolving lines of credit. In general, as our sales volume increases, our net investment in working capital increases, which typically results in decreased cash flow from operating activities. Conversely, when sales volume decreases, our net investment in working capital typically decreases, which typically results in increased cash flow from operating activities.
Our cash and cash equivalents balance totaled $146.3 million at March 31, 2025, compared to $185.5 million at June 30, 2024, including $33.3 million and $20.0 million held outside of the United States at March 31, 2025 and June 30, 2024, respectively. Checks released but not yet cleared in the amount of $0.2 million and $5.9 million are included in accounts payable at March 31, 2025 and June 30, 2024, respectively.
We conduct business primarily in the United States, Canada and Brazil where we generate and use cash. We provide for United States income taxes from the earnings of our Canadian and Brazilian subsidiaries. See Note 13 - Income Taxes in the Notes to the Consolidated Financial Statements for further discussion.
Our net investment in working capital, defined as accounts receivable plus inventories less accounts payable, decreased $7.9 million to $498.3 million at March 31, 2025 from $506.2 million at June 30, 2024, primarily from decreases in inventory and accounts receivable, partially offset by lower accounts payable, as a result of lower sales volume and our focus on working capital efficiency. Our net investment in working capital is affected by several factors such as fluctuations in sales volume, net income, timing of collections from customers, increases and decreases to inventory levels and payments to vendors.

| Nine months ended
| March 31,
| 2025 |  | 2024
| (in thousands)
Cash provided by (used in): |
Operating activities | $ | 104,704 |  |  | $ | 316,908 |
Investing activities | (59,873) |  |  | 10,693 |
Financing activities | (83,424) |  |  | (203,941) |

Operating cash flows are subject to variability period over period as a result of the timing of payments related to accounts receivable, accounts payable, and other working capital items. Net cash provided by operating activities was $104.7 million and $316.9 million for the nine months ended March 31, 2025 and March 31, 2024, respectively. Cash provided by operating activities for the nine months ended March 31, 2025 is primarily attributable to net income adjusted for non-cash items plus reductions in accounts receivable and inventory partially offset by a reduction in accounts payable. Compared to March 31, 2024, accounts receivable and inventory decreased 4.6% and 10.0% respectively, while accounts payable decreased 2.7%.
The number of days sales outstanding ("DSO") was 72 days at March 31, 2025 and 71 days at March 31, 2024. Inventory turned 5.0 times during the quarter ended March 31, 2025, compared to 4.8 times in the prior-year quarter ended March 31, 2024.
Cash used in investing activities for the nine months ended March 31, 2025 was $59.9 million, compared to cash provided by investing activities of $10.7 million in the prior-year period. Cash used in investing activities for the nine months ended March 31, 2025 is largely due to cash paid for acquisitions and capital expenditures. Cash provided by investing activities for the nine months ended March 31, 2024 represents the proceeds from the sale of a business offset by capital expenditures.
Management expects capital expenditures for fiscal year 2025 to range from $7.0 million to $9.0 million, primarily for IT investments.
For the nine months ended March 31, 2025 and March 31, 2024, cash used in financing activities totaled $83.4 million and $203.9 million, respectively. Cash used in financing activities for the nine months ended March 31, 2025 is primarily attributable to common stock repurchases in the nine months. Cash used in financing activities for the nine months ended March 31, 2024 is primarily attributable to repayments of borrowings on the revolving credit facility.
44

Table of Contents
Credit Facility
We have a multi-currency senior secured credit facility with JPMorgan Chase Bank N.A., as administrative agent, and a syndicate of banks (as amended, the “Amended Credit Agreement”). On September 28, 2022, we amended and restated our Amended Credit Agreement, which includes (i) a five-year, $350 million multicurrency senior secured revolving credit facility and (ii) a five-year $150 million senior secured term loan facility. The Amended Credit Agreement extended the credit facility maturity date to September 28, 2027. In addition, pursuant to an “accordion feature,” we may increase our borrowing limits up to an additional $250 million, subject to obtaining additional credit commitments from the lenders participating in the increase. The Amended Credit Agreement allows for the issuance of up to $50 million for letters of credit. Borrowings under the Amended Credit Agreement are guaranteed by substantially all of our domestic subsidiaries and secured by substantially all of our domestic assets. Under the terms of the revolving credit facility, the payment of cash dividends is restricted. We incurred debt issuance costs of $1.4 million in connection with the amendment and restatement of the Amended Credit Agreement. These costs were capitalized to other non-current assets on the Condensed Consolidated Balance Sheets and added to the unamortized debt issuance costs from the previous credit facility.
Loans denominated in U.S. dollars, other than swingline loans, bear interest at a rate per annum equal to, at our option, (i) the adjusted term SOFR or adjusted daily simple SOFR plus an additional margin ranging from 1.00% to 1.75% depending upon our ratio of (A) total consolidated debt less up to $30 million of unrestricted domestic cash to (B) trailing four-quarter consolidated EBITDA measured as of the end of the most recent year or quarter, as applicable, for which financial statements have been delivered to the Lenders (the “leverage ratio”); or (ii) the alternate base rate plus an additional margin ranging from 0% to 0.75%, depending upon our leverage ratio, plus, if applicable, certain mandatory costs. All swingline loans denominated in U.S. dollars bear interest based upon the adjusted daily simple SOFR plus an additional margin ranging from 1.00% to 1.75% depending upon our leverage ratio, or such other rate as agreed upon with the applicable swingline lender. The adjusted term SOFR and adjusted daily simple SOFR include a fixed credit adjustment of 0.10% over the applicable SOFR reference rate. Loans denominated in foreign currencies bear interest at a rate per annum equal to the applicable benchmark rate set forth in the Amended Credit Agreement plus an additional margin ranging from 1.00% to 1.75%, depending upon our leverage ratio plus, if applicable, certain mandatory costs.
During the quarter and nine months ended March 31, 2025, our borrowings under the Amended Credit Agreement were U.S. dollar loans. The spread in effect as of March 31, 2025 was 1.00% for SOFR-based loans and 0.00% for alternate base rate loans. The commitment fee rate in effect at March 31, 2025 was 0.15%. The Amended Credit Agreement includes customary representations, warranties and affirmative and negative covenants, including financial covenants. Specifically, our Leverage Ratio must be less than or equal to 3.50 to 1.00 at all times. In addition, our Interest Coverage Ratio (as such term is defined in the Amended Credit Agreement) must be at least 3.00 to 1.00 at the end of each fiscal quarter. In the event of a default, customary remedies are available to the lenders, including acceleration and increased interest rates. We were in compliance with all covenants under the credit facility at March 31, 2025.
The average daily outstanding balance on the revolving credit facility, excluding the term loan facility, during the nine month periods ended March 31, 2025 and 2024 was $0.3 million and $94.6 million, respectively. There was $350.0 million and $349.9 million available for additional borrowings as of March 31, 2025 and June 30, 2024, respectively. The effective interest rates for the revolving line of credit were 5.45% and 6.44% as of March 31, 2025 and June 30, 2024, respectively. There were no letters of credit issued under the multi-currency revolving credit facility at March 31, 2025 or June 30, 2024. Availability to use this borrowing capacity depends upon, among other things, the levels of our Leverage Ratio and Interest Coverage Ratio, which, in turn, will depend upon (1) our Credit Facility Net Debt relative to our Credit Facility EBITDA and (2) Credit Facility EBITDA relative to total interest expense, respectively. As a result, our availability will increase if EBITDA increases (subject to the limit of the facility) and decrease if EBITDA decreases. While we were in compliance with the financial covenants contained in the Amended Credit Agreement as of March 31, 2025, and currently expect to continue to maintain such compliance, should we encounter difficulties, our historical relationship with our Amended Credit Agreement lending group has been strong and we anticipate their continued support of our long-term business.
Summary
We believe that our existing sources of liquidity, including cash resources and cash provided by operating activities, supplemented as necessary with funds under our credit agreements, will provide sufficient resources to meet our present and future working capital and cash requirements for at least the next twelve months. We also believe that our longer-term working capital, planned expenditures and other general funding requirements will be satisfied through cash flows from operations and, to the extent necessary, from our borrowing facilities.
45

Table of Contents
Accounting Standards Recently Issued
See Note 1 of the Notes to Condensed Consolidated Financial Statements for a full description of recent accounting pronouncements, including the anticipated dates of adoption and the effects on our consolidated financial position and results of operations.
Critical Accounting Policies and Estimates
Critical accounting policies are those that are important to our financial condition and require management's most difficult, subjective or complex judgments. Different amounts would be reported under different operating conditions or under alternative assumptions. See Management's Discussion and Analysis of Financial Condition and Results from Operations in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024 for a complete discussion.
46

Table of Contents

Item 3. | Quantitative and Qualitative Disclosures About Market Risk

For a description of our market risks, see Part II, Item 7A. "Quantitative and Qualitative Disclosures About Market Risk" in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024. No material changes have occurred to our market risks since June 30, 2024.
47

Table of Contents

Item 4. | Controls and Procedures

An evaluation was carried out under the supervision and with the participation of our management, including our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO") of the effectiveness of our disclosure controls and procedures at March 31, 2025. Based on that evaluation, our management, including the CEO and CFO, concluded that our disclosure controls and procedures are effective at March 31, 2025. During the quarter ended March 31, 2025, there was no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
48

Table of Contents
PART II. OTHER INFORMATION

Item 1. | Legal Proceedings

The Company is, from time to time, party to lawsuits arising out of operations. Although there can be no assurance, based upon information known to us, we believe that any liability resulting from an adverse determination of such lawsuits would not have a material adverse effect on our financial condition or results of operations. For a description of our material legal proceedings, see Note 12 - Commitments and Contingencies in the notes to the condensed consolidated financial statements, which is incorporated herein by reference.

Item 1A. | Risk Factors

In addition to the risk factors discussed in our other reports and statements that we file with the SEC, you should carefully consider the factors discussed in Part I, Item 1A. "Risk Factors" in our Annual Report on Form 10-K for the year ended June 30, 2024, which could materially affect our business, financial condition and/or future operating results.
There have been no material changes to the risk factors disclosed in Item 1A of our Annual Report on Form 10-K for the fiscal year ended June 30, 2024.

Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds

Share Repurchases
In May 2024, our Board of Directors approved a $100.0 million share repurchase authorization. The authorization does not have any time limit.
The following table presents the share-repurchase activity for the quarter ended March 31, 2025:

Period |  | Total number of shares purchased (1) |  | Average price paid per share |  | Total number of shares purchased as part of the publicly announced plan or program |  | Approximate dollar value of shares that may yet be purchased under the plan or program
January 1 - 31, 2025 |  | 195,000 |  |  | $ 48.22 |  | 195,000 |  |  | $ 61,564,334
February 1 - 28, 2025 |  | 261,732 |  |  | $ 38.06 |  | 261,732 |  |  | $ 51,601,877
March 1 - 31, 2025 |  | 262,861 |  |  | $ 36.08 |  | 262,461 |  |  | $ 42,131,321
Total |  | 719,593 |  |  |  |  | 719,193 |  |  | $ 42,131,321

(1) Shares withheld from employees' stock-based awards to satisfy required tax withholding obligations totaled 400 for the month of March 2025. There were no shares withheld during the months of January and February 2025.
Subsequent to March 31, 2025, our Board of Directors approved a new $200.0 million share repurchase authorization increasing the current remaining availability. The authorization does not have any time limit.
Dividends
We have never declared or paid a cash dividend. Under the terms of our credit facility, the payment of cash dividends is restricted.
49

Table of Contents

Item 5. | Other Information

During the three months ended March 31, 2025, none of our directors or our officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933), except as follows:
On March 20, 2025, Rachel Hayden, our Senior Vice President and Chief Information Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) and that provides for the sale of up to 5,374 shares of our common stock, subject to certain conditions until February 2, 2026 (or an earlier date on which all transactions under the trading arrangement have been completed or certain other events occur).
50

Table of Contents

Item 6. | Exhibits

Exhibit Number | Description
31.1 (a) | Certification of the Chief Executive Officer, Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2 (a) | Certification of the Chief Financial Officer, Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1 (b) | Certification of the Chief Executive Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2 (b) | Certification of the Chief Financial Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101 (a) | The following materials from our Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets at March 31, 2025 and June 30, 2024; (ii) the Condensed Consolidated Income Statements for the quarters and nine months ended March 31, 2025 and 2024; (iii) the Condensed Consolidated Statements of Comprehensive Income for the quarters and nine months ended March 31, 2025 and 2024; (iv) the Condensed Consolidated Statements of Shareholder's Equity for the quarters and nine months ended March 31, 2025 and 2024; (v) the Condensed Consolidated Statements of Cash Flows for the nine months ended March 31, 2025 and 2024; and (vi) the Notes to the Condensed Consolidated Financial Statements. The instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL
104 (a) | Cover page Inline XBRL File (Included in Exhibit 101)
(a) | Filed herewith
(b) | Furnished herewith

51

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  | ScanSource, Inc.
Date: | May 8, 2025 | /s/ MICHAEL L. BAUR
|  | Michael L. Baur
|  | Chair, President and Chief Executive Officer (Principal Executive Officer)

Date: | May 8, 2025 | /s/ STEVE JONES
|  | Steve Jones
|  | Senior Executive Vice President and Chief Financial Officer (Principal Financial Officer)

Date: | May 8, 2025 | /s/ BRANDY FORD
|  | Brandy Ford
|  | Senior Vice President and Chief Accounting Officer (Principal Accounting Officer)

52